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Summary 
The human retina is a complex neurosensory system that features multiple layers of 
different retinal neurons. Those neurons are arranged in a unique architecture and function 
to transmit a signal to the human brain that is interpreted as visual perception. Vision 
impairment is affecting millions of people worldwide while at the same time, for many 
disorders, pharmacological treatment options are not available or can only ameliorate the 
symptoms. To be able to investigate underlying disease mechanisms and to find new 
pharmacologic treatment options, new retina models are urgently required. Up to now, 
there are several different retinal model systems available, ranging from animal models to in 
silico as well as in vitro cell culture models. These systems differ considerably in their 
advantages and applicability. However, the limitations of each system lead to the 
consequence that a new and physiological accurate model system is necessary that is able to 
represent the human retina biology with all of its cell types as precisely as possible. Retinal 
organoids (ROs) as miniature “retina in a dish” have the potential to serve as new in vitro 
model system. They feature all retinal layers, can be generated from healthy human cells but 
also from patient material. Here especially, they can serve as disease model and allow to test 
potential treatment options. However, standard dish culture of these organoids leads to 
several limitations since the tissues’ natural environment is not considered. 
This thesis substantially contributed to the development of a new microfluidic retina-on-a-
chip (RoC) system. For this purpose, we combined RO-technology with organ-on-a-chip 
technology (OoC). OoC technology uses microfluidic devices for cell-culture to simulate an 
organ-like physiology. We used ROs as well as retinal pigment epithelium (RPE) cells derived 
from human induced pluripotent stem cells by retinal differentiation to integrate them into a 
microfluidic chip system. 
By first establishing individual culture chips for monoculture of RPE or ROs alone, we verified 
that both tissues are viable and can be cultured in the chip environment. Using 
immunohistochemistry and qRT-PCR we showed that characteristic markers expression is not 
affected and using electron microscopy that the typical morphology is preserved.   
The chips were then combined into a co-culture RoC system, enabling the cultivation of ROs 
in close contact with RPE cells.  
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We verified that it was possible to bring both tissues into a physiological and close contact by 
analyzing the distance between RPE and RO inside the chip using live-cell imaging and 
immunohistochemistry. 
Further, we found that the setup inside the RoC leads to improved segment formation in the 
photoreceptors of the ROs. This was shown in a qualitative fashion using 
immunohistochemistry and also in a quantitative fashion, using electron microscopic 
comparisons between dish-cultured and chip-cultured ROs. In this context, we also observed 
a positive impact of the presence of RPE inside the chip regarding photoreceptor segment 
formation. 
As another functionality test to show a physiological setup, we analyzed the phagocytotic 
ability of the RPE cells for digestions of shed photoreceptors segments inside the RoC. Using 
live-cell imaging, immunohistochemistry and electron microscopy, we were able to confirm 
phagocytosis inside the RPE layer within the RoC. 
Lastly, as a proof-of-principle study, we showed that the RoC is suitable as an in vitro drug-
testing device for analysis of retinal toxicity. The known retinopathic effect of two different 
drugs, chloroquine and gentamicin, was verified by analyzing cell death with live-cell imaging 
of treated RoCs and subsequent quantitative comparison to non-treated RoCs. In the case of 
chloroquine, also the known lysosomotropic effect was verified using immunohistochemistry. 
In summary, we have generated a new and physiological microfluidic retina-on-a-chip  
system that helps to improve RO generation and maturation. This system represents a new 
retinal model system and is suitable not only for testing of candidate or established drugs 
regarding retinal toxicity, but it has the outmost potential to serve as a disease model to 
identify new pharmacological treatment options as well as underlying disease mechanisms. 
- 1 - 
 
 
1. Introduction 
1.1. The anatomy of the human eye 
 
Figure 1: Anatomy of the human eye. 
Anatomy of the human eye adapted from (Haderspeck et al., 2019) showing the most important structures 
that are part of the three primary layers of the human eye. The external layer is formed by the sclera and 
the cornea (and conjunctiva). The intermediate layer consists of choroid, iris, ciliary body, zonula fibers and 
lens. The internal layer of the eye consists of the retina as neurosensory structure. The eyeball is filled by 
the vitreous body. 
 
The human eye is a slightly asymmetrical, spherical structure consisting of three primary 
layers (Kolb, 1995): The external, the intermediate and the internal layer as well as its 
accessory structures like the eye lids, the lacrimal apparatus, extra- and intraocular muscles 
(Kolb, 1995; Rehman and Bhimji, 2018). The cavity of this eyeball is filled with a gel-like mass 
called the vitreous body. For an overview on the anatomy of the human eye, see Figure 1. 
The outermost layer consists of a dense and white fibrous tunic and is called sclera. It mainly 
provides structural stability and a window to the outside environment with the cornea as 
transparent structure at the anterior side (McCaa, 1982). Its transparency is only possible 
due to a specialized arrangement of cells and collagenous fibrils, due to the absence of blood 
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vessels and a state of relative dehydration (McCaa, 1982). Further, the anterior part of the 
eyeball, where the sclera is visible, is covered with a mucous membrane, called the 
conjunctiva, that also covers the inner surface of the eyelids (Estlack et al., 2017). 
The intermediate layer of the eye is called the uvea and forms a vascularized layer at the 
posterior side, the choroid, necessary to provide nutrition especially to the inner layer. 
Moreover, the uvea also includes the iris, that acts as a diaphragm, and the ciliary body 
which regulates the shape of the lens during accommodation and further also produces 
aqueous humor (McCaa, 1982).  
Finally, the complex neurosensory structure that is responsible for visual perception is found 
as the innermost layer of the eye and is called retina. Since this thesis focuses mainly on the 
generation and applicability of retinal cells, this tissue will be highlighted in greater detail 
within the next section.  
1.1.1. Anatomy and physiology of the human retina 
 
Figure 2: The layers of the human retina. 
The layers of the retina adapted from (Haderspeck et al., 2019) showing the inner limiting membrane 
(ILM), the nerve fiber layer (NFL), the retinal ganglion cell layer (GCL), the inner plexiform layer (IPL), the 
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inner nuclear layer (INL), the outer plexiform layer (OPL), the outer nuclear layer (ONL), the outer limiting 
membrane (OLM), the photoreceptor (PR) layer and the retinal pigment epithelium (RPE). 
The retina consists of three cellular layers with plexiform layers for synaptic transmission in 
between as well as limiting membranes to border the retinal tissue. A detailed 
representation of the retina is depicted in Figure 2 including: the inner limiting membrane 
(ILM); the nerve fiber layer (NFL); the retinal ganglion cell layer (GCL); the inner plexiform 
layer (IPL); the inner nuclear layer (INL); the outer plexiform layer (OPL);  the outer nuclear 
layer (ONL); the outer limiting membrane (OLM); the photoreceptor (PR) layer. The non-
neural part of the retina is formed by the retinal pigment epithelium (RPE) (Hoon et al., 
2014; Kels et al., 2015; McCaa, 1982). 
The light signal as the visual stimulus enters the eye and is refracted by three structures 
including the cornea, the lens and the vitreous body, to be then focused onto the retina. It is 
then absorbed by photopigments in the outer segments of the photoreceptor cells and 
converted into an electrical stimulus (Purves and Williams, 2001). Further, this signal is 
passed through the outer plexiform layer (OPL), where synaptic transmission occurs, and 
then to the inner nuclear layer (INL), where the cell bodies of the three main classes of 
interneurons reside, that further integrate and modulate the signal (Purves and Williams, 
2001). These interneurons are the bipolar cells, the amacrine cells and the horizontal cells 
(Purves and Williams, 2001). Finally, the modified signal is passed via synapses in the inner 
plexiform layer (IPL) to the retinal ganglion cells inside the ganglion cell layer (GCL) (Purves 
and Williams, 2001). These cells have long axons, forming the optic nerve, that is responsible 
for transmission of the visual information to the brain (Purves and Williams, 2001). Besides 
the neurons inside the retina, also glial cells can be found, including microglia, astrocytes as 
well as Müller glia that fulfill a multitude of different functions (Bringmann et al., 2006; de 
Souza et al., 2016). The non-neural part of the retina is formed by a pigmented layer for light 
absorption called retinal-pigment epithelium (RPE) that is located distally to the 
photoreceptor outer segments. 
1.1.2. Cell types of the retina  
As previously mentioned, the retina consists of five major classes of neuronal cells, as well as 
additional cell types like Müller glia and RPE cells (Hoon et al., 2014). This paragraph will 
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discuss the characteristics of the main cell types relevant for this thesis, including their main 
functions. In addition, each cell type’s typically expressed marker proteins are mentioned, 
which plays an important role for verification of different cell types in this study. 
1.1.2.1. Photoreceptor cells 
Photoreceptor cells make up the vast majority of cell types in the retina and have a very 
unique and polarized structure, divided into an inner and outer segment by a connecting 
cilium (Li et al., 2015; Molday and Moritz, 2015). While the inner segment contains most of 
the photoreceptor cell’s organelles, the outer segment consists of stacks of membrane disks 
that contain photopigments to absorb light (Molday and Moritz, 2015). The transformation 
of photons of light into an electrical signal is initiated in the photoreceptor outer segments 
via conformational change of the vitamin A-derivate retinal, that is bound to an opsin 
protein leading to a signal cascade (Baylor, 1996; Molday and Moritz, 2015; Purves and 
Williams, 2001). This process, called phototransduction, ultimately leads to photoreceptor 
hyperpolarization and therefore to a reduced release of the photoreceptors’ 
neurotransmitter glutamate (Purves and Williams, 2001; de Souza et al., 2016). As a 
consequence, this graded transmitter release results in action potentials and signal 
transmission in the downstream retinal neurons (Purves and Williams, 2001). 
Photoreceptor cells are classified into rod and cone photoreceptors with both classes 
differing in light and wavelength-specific sensitivity depending on the opsin-type present 
(Hoon et al., 2014; de Souza et al., 2016). While rods are very sensitive to light and therefore 
responsible for dim-light scotopic vision, cones are less sensitive in general, but each cone 
photoreceptor type has specific wavelength sensitivity (Hoon et al., 2014). Hence, cone 
photoreceptors are mainly used for photopic vision under bright-light conditions and are 
capable of high-acuity color vision (Hoon et al., 2014). 
Rod and cone photoreceptors also divide the signal pathway through the retina into two 
separate pathways, the rod and cone pathway, that both involve specific kinds of subtypes 
of bipolar cells, amacrine cells and ganglion cells and are responsible for processing different 
kinds of visual stimuli (de Souza et al., 2016). 
Photoreceptor cells are often identified using specific markers for the opsin protein they 
express. For example, the opsin present in rods that is called rhodopsin, is an obvious and 
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very specific marker for rod photoreceptor cells (de Souza et al., 2016). Cones on the other 
hand, either express opsins with long (L), medium (M), or short (S) wavelength sensitivity 
and can be marked accordingly (de Souza et al., 2016). Moreover, all proteins involved in the 
signal cascade of phototransduction can be used as markers, including e.g. transducin, 
arrestin, or recoverin (Lerea et al., 1989; de Souza et al., 2016). 
As specific marker proteins for photoreceptor outer segments, ROM-1 as well as peripherin-
2 (PRPH2), both homologous membrane proteins of the disk rims, can be used (Clarke et al., 
2000). 
1.1.2.2. Interneurons of the retina 
The bipolar cells are the interneurons responsible for vertical signal transmission from the 
photoreceptors to the ganglion cells (de Souza et al., 2016). As their name implies, they have 
a bipolar morphology, forming synapses on both sides. Bipolar cells can be further 
subdivided into several different cone bipolar cell types and one rod bipolar cell type (de 
Souza et al., 2016), moreover, also according to whether they hyperpolarize (OFF-BCs) or 
depolarize (ON-BCs) in response to a light stimulus (de Souza et al., 2016). This subdivision 
presents itself on the level of characteristic marker expression. Protein kinase C-α (PKC-α 
PRKCA) is a typical marker for rod BCs (Haverkamp et al., 2003). Its colocalization with ISLET-
1, a marker for all ON-BCs, allows to discriminate the rod from the cone ON-BCs (de Souza et 
al., 2016). One typical marker used to label OFF-BCs is calbindin (Haverkamp et al., 2003; de 
Souza et al., 2016). 
 
Horizontal cells and amacrine cells are the interneurons involved in horizontal signal 
transmission, also called the “lateral” pathway, responsible for modulating the vertical signal 
(de Souza et al., 2016). 
The role of the horizontal cells in this context is negative feedback to cones and bipolar cells 
through inhibitory synapses after receiving an excitatory input from photoreceptors (de 
Souza et al., 2016). Calbindin and ISLET-1 are also markers that can be used for horizontal 
cell, in addition to bipolar cells. The homeodomain protein PROX1, which regulates 
progenitor proliferation, was shown to be a marker of developing horizontal cells but for 
amacrine cells as well (Dyer et al., 2003; Pérez de Sevilla Müller et al., 2017). 
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Amacrine cells are in contact with bipolar cells and ganglion cells, as well as other amacrine 
cells (de Souza et al., 2016). This cell type can be identified by markers for inhibitory 
synapses like GABA and glycine (de Souza et al., 2016). With more than 24 different types, 
amacrine cells have the highest number of known subtypes that have been identified so far, 
based on morphology (Kolb et al., 1992). The most common type, the AII amacrine cells that 
mediate the rod pathway, are positive for the marker calretinin in humans (de Souza et al., 
2016). 
1.1.2.3. Ganglion cells 
Ganglion cells are the last neurons of the retina before the visual signal is transmitted to 
higher visual centers via their long axons that are bundled as the optic nerve (Hoon et al., 
2014; Purves and Williams, 2001). The ganglion cells receive input from bipolar cells as well 
as amacrine cells (de Souza et al., 2016). Different subtypes of retinal ganglion cells are 
categorized based on their projections to different layers of the lateral geniculate nucleus, or 
based on their response to light or their morphology (Baden et al., 2016; Farrow and 
Masland, 2011; Xiang et al., 1995). The existence of these different retinal ganglion cell 
subtypes that are involved in different pathways is a prerequisite for some of the most 
complex features of the retina, such as color vision, fine feature analysis, or direction 
selectivity (Elstrott et al., 2008; Masland, 2012; Shapley and Hugh Perry, 1986; de Souza et 
al., 2016; Yin et al., 2009). 
Since this cell type has long axonal processes, typical neuronal markers, such as the 
microtubule marker beta-III tubulin, can be used to identify retinal ganglion cells (Jiang et al., 
2015). The most common markers for ganglion cells, however, are the POU-domain proteins 
of the BRN3 family that are essential transcription factors. In addition, the BRN3 expression 
patterns allow a cell subtype specification (Sajgo et al., 2017; de Souza et al., 2016; Xiang et 
al., 1995). A very specific subtype of retinal ganglion cells, the intrinsically photosensitive 
ganglion cells can be marked using antibodies against melanopsin (Dacey et al., 2005).  
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1.1.2.4. Müller cells 
Müller glia are the major glia cell type of the retina, spanning all layers and forming a sheath 
around all retinal neurons (Bringmann et al., 2006). The processes of Müller glia also form 
the so-called inner and outer limiting membrane (ILM and OLM) that are essential as distal 
and proximal barriers of the retina and to separate an ionically distinct compartment 
(Massey, 2006). Thus, Müller glia keep the structural integrity of the retina through 
mechanical strength (Omri et al., 2010). 
Moreover, Müller cells also play several essential roles for homeostatic and metabolic 
support e.g. by providing nutrition to retinal neurons, by regulating ion and water 
homeostasis and recycling of neurotransmitters (Bringmann et al., 2006; Hoon et al., 2014). 
Glutamine synthetase (GLUL) is an enzyme that is expressed by Müller glia to break-down 
the neurotransmitter Glutamate released from retinal neurons and is therefore one of the 
most commonly used markers for this cell type (Bringmann et al., 2006). Further, the 
annexin family of angiogenic and anti-inflammatory proteins was identified by proteomic 
profiling of Müller cells and allows them to be distinguished from microglia cells (Grosche et 
al., 2016). The member of this family used as a marker in this work was Annexin A4 (ANXA4). 
In the OLM, typical adherens junction and tight junction proteins can be found as marker 
proteins, such as zonula occludens 1 (ZO1), occludin and junction adhesion molecule (JAM) 
(Omri et al., 2010). 
1.1.2.5. Retinal pigment epithelium 
Another part of the retina is the pigmented monolayer of quasi-hexagonal cells, which is 
located adjacent to the photoreceptor cells, and is referred to as RPE (Kiser et al., 2014). In 
these cells, the pigment melanin is found in granules called melanosomes and is essential to 
absorb scattered light. Therefore, it is of obvious importance to improve the quality of the 
light signal (Purves and Williams, 2001; Strauss, 1995). But besides this central function, the 
RPE fulfills many other tasks that are especially important for the survival of photoreceptor 
cells (Molday and Moritz, 2015). 
The RPE forms tight junction barriers and in this way, is part of the blood-retinal barrier, 
allowing selective transport of water and metabolic products coming from the retina, as well 
as transport of nutrients and vitamin A towards the retina (Steinberg, 1985; Strauss, 1995). 
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Further, the epithelial transport via the RPE controls ion homeostasis in the subretinal space 
(Strauss, 1995). Another function of RPE is the communication with both neighboring 
tissues, the retinal cells on one side and the endothelium of the choroid on the other side 
(Steinberg, 1985; Strauss, 1995). This communication happens via secretion of different 
signaling molecules, for example ATP, fibroblast growth factors (FGFs), insulin-like growth 
factor-1 (IGF-1), vascular endothelial growth factor (VEGF) or pigment epithelium-derived 
growth factor (PEDF). VEGF is a factor that is released towards the basolateral side of the 
cell, which means towards the choroid. VEGF as secreted factor mediates paracrine survival 
signals for the fine fenestrated endothelium of the choriocapillaries (Witmer et al., 2003). A 
factor that is secreted predominantly to the retinal, apical side of the RPE is PEDF, a 
neurotrophic factor that even has a protective effect against retinal injury and ischemia 
(Becerra et al., 2004; Ogata et al., 2001).  
This functional polarization also appears as a morphological polarization of the cells, since 
prominent microvilli processes are only formed on the apical side, to increase surface 
contact with the outer segments of photoreceptors (Kiser et al., 2014). As a marker for this 
apical microvilli formation, the membrane protein Ezrin can be used (Kivelä et al., 2000). 
Further signs of the characteristic RPE polarization is, for example, the basolateral 
expression of the ion channel Bestrophin 1 (BEST1) (Kay et al., 2013; Marmorstein et al., 
2000).  
Moreover, a functional interaction of photoreceptors and RPE cells is necessary for the visual 
cycle. The visual cycle involves the regeneration of the chromophore retinal that is required 
for light absorption in its 11-cis form in the photoreceptor outer segments (Kiser et al., 
2014). Via photoisomerization, 11-cis retinal changes its conformation into all-trans retinal 
which dissociates from rhodopsin and needs to be isomerized back into its 11-cis 
conformation via several intermediate steps (Kiser et al., 2014). Part of this enzymatic re-
isomerization is performed by the retinoid isomerase RPE65 and takes place in the RPE cells, 
and therefore retinal needs to be shuttled to and from the RPE (Kiser et al., 2014; Molday 
and Moritz, 2015; Saari, 2012). 
The process of photo-oxidation in the photoreceptor outer segments inevitably leads to 
damage to the segment tips (Kevany and Palczewski, 2010). Therefore, photoreceptors 
constantly shed their tips and renew their outer segments from the base to stay functional 
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(Kevany and Palczewski, 2010). These shed outer segment tips are phagocytosed by the RPE 
cells and unnecessary material is degraded (Steinberg, 1985).  
To summarize, the turnover of outer segments, the maintenance of photoreceptor cells as 
well as many other interactions between RPE and the neural retina shows the importance of 
this simple monolayer of pigmented cells for vision. 
1.2. Development of the human retina 
In this thesis, we used retinal cells that have been derived from stem cells via retinal 
differentiation. Therefore, it is essential to understand the normal process of retinal 
development in vivo to then be able recapitulate this process in vitro and classify the stage 
of retinal maturity within our model system. A schematic timeline of embryonic 
development including the formation of the retina is provided in Figure 3. 
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Figure 3: Development of the human retina. 
 Some of the pluripotent stem cells from the inner cell mass (the embryoblast) of the blastocyst will be 
directed to become neuroectoderm. Neural induction leads to formation of the neural plate that contains 
neuroepithelial cells. A retinal field develops at the cranial end of the neural plate. Optic vesicles (OV) 
appear as evaginations from the retinal field. Retinal progenitor cells can be found in the OV. The anterior 
part of the OV that will develop into neural retina invaginates to form the optic cup. Posterior parts of the 
optic cup will develop into RPE. Figure adapted from Achberger et al., 2019a. 
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Eye development in humans starts around day 22 of embryonic development (Paquette et 
al., 2009) (Figure 3). The retina is derived from the developing diencephalon during the stage 
of the neural plate when the neural tube starts to form (Fuhrmann, 2010; Purves and 
Williams, 2001). At this time, first retinal progenitor cells (RPCs) can be found inside a single 
retinal field at the cranial end of the neural plate (Li et al., 1997). Towards the rostral side, 
evaginations are formed that are initially called optic grooves. While the neural tube 
develops through an upfolding of the neural plate, these optic grooves on each side 
evaginate further and are referred to as optic vesicles (OV) after that event (Kolb, 1995; 
Lamb et al., 2007). The developing vesicle is in contact with parts of the surface ectoderm 
(the lens placode), leading to the induction of further differentiation steps in both tissues 
(Fuhrmann, 2010; Lamb et al., 2007). Subsequently, the optic vesicles are folding inwards to 
form a cup-like structure referred to as optic cup. Later, the inner layer of this cup forms the 
neural part of the retina, while the outer layer forms the RPE (Fuhrmann, 2010). Meanwhile, 
the surface ectoderm is folding in towards the optic cup and develops the lens. 
Consequently, retina and lens have different developmental origins. After both layers of the 
optic cup are in contact, early retinal ganglion cells start to send their axons out crossing the 
retinal surface. The eye cup continues growing and finally seals at the region of the choroidal 
fissure (Fuhrmann, 2010; Lamb et al., 2007).  
However, the cells of the developing retina are not born at the same time. Moreover, the 
order in which the different retinal cell classes appear during development seems to be a 
highly conserved mechanism in all vertebrates (Lamb et al., 2007). Retinal ganglion cells, 
horizontal cells, amacrine cells, as well as cone photoreceptors are born first and therefore 
referred to as “early-born” retinal neurons, while rod photoreceptors, bipolar cells, and 
Müller glia are “late-born” retinal cells (Bassett and Wallace, 2012). Nevertheless, despite 
their different time points of cell genesis, all retinal neurons, the RPE as well as the Müller 
glia, are generated from the multipotent retinal progenitor cells (RPCs) mentioned before.  
1.2.1. Characteristic marker expression during retinal 
differentiation 
Both, tissue-tissue interactions, as well as intrinsic signals play important roles throughout 
the process of retinal development (Fuhrmann, 2010). Here, some of the most important 
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specific extrinsic and intrinsic signals will be described with focus on the transcription factors 
involved since they also represent important markers for developing retinal cells. Regulatory 
marker molecules are important within this work to identify retinal cell types and also to 
stage their maturity and are therefore mentioned in greater detail. 
Early retinal progenitor cells at the optic vesicle stage express the transcription factors 
CHX10 (ceh-10 homeodomain containing homolog, also called VSX2, visual system 
homeobox 2) and MITF (microphthalmia-associated transcription factor). While the RPE 
continues to express MITF, its expression is downregulated in the developing neural parts of 
the retina, predominantly due to FGF signaling (Nguyen and Arnheiter, 2000). 
The sequence in which retinal cells are born follows a defined chronological order and a 
hierarchical gene regulation mechanism (Marquardt, 2003; Mu and Klein, 2004). These RPCs 
show a multipotent differentiation ability that allows them to generate different retinal cell 
types (Marquardt, 2003; Wetts and Fraser, 1988). Throughout this process they are adopting 
a series of defined and irreversible competence states influenced by secreted factors 
including TGFβ, EGF, SHH, NGF, LIF, and CNTF (Bassett and Wallace, 2012; Marquardt, 2003).  
At the top of this hierarchical network are homeobox transcription factors like PAX6, RAX, 
CHX10, SIX3 and LHX2 which are expressed in all retinal progenitors (Marquardt, 2003; Mu 
and Klein, 2004). PAX6 in this context plays an important role during eye field specification 
and keeps RPCs in their multipotent state (Marquardt et al., 2001; Mu and Klein, 2004). 
For each specific retinal cell type, there are several key intrinsic regulators directing the cell 
fate. For example, photoreceptor cell fate is determined by transcription factors such as 
NRL, CRX and OTX2 whereas ATOH7 (MATH5), ISLET-1, NEUROD1 and BRN3 are involved in 
retinal ganglion cell-differentiation (Bassett and Wallace, 2012).  
 
1.3. Retinal model systems 
1.3.1. Overview on existing retinal model systems and their 
limitations 
To highlight the necessity for a new and physiological accurate human retinal model system, 
this chapter will briefly summarize existing model systems in the field, explain their 
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applications and point out the limitations of the respective system. Existing systems include 
animal models (in vivo), theoretical models (in silico), retinal explants (ex vivo), 2D and 3D in 
vitro models. 
 
Figure 4: Overview on existing retinal model systems. 
Current retinal model systems include animal models (in vivo), theoretical or mathematical models (in 
silico), explant cultures (ex vivo), as well as 2D and 3D cell culture models (in vitro). Figure adapted from 
(Haderspeck et al., 2019). 
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1.3.2. Animal models 
According to J.C. Zeiss, professor of comparative medicine, a suitable animal model 
“elucidates some fundamental aspects of a human disease to promote greater 
understanding of its mechanism” (Zeiss, 2013). 
For disease modeling, where hereditary or transgenic models are usually required, rodents 
are still one of the most widely used model systems (Kompella et al., 2010). There are many 
mouse strains available to study retinal disease and development, especially concerning 
microphthalmia, glaucoma or genetic retinal degeneration (Hafezi et al., 2000; Zeiss, 2013). 
Besides, for every specific experimental ocular disease, different animal model systems are 
favored and necessary. For this reason, for example primates are the primarily used species 
in age-related macular degeneration (AMD) studies (Turgut and Karanfil, 2017). 
Pharmacokinetic studies for ophthalmic drug development on the other hand, rely on testing 
animals like dogs, pigs, rabbits or monkeys, mainly because of the size of the eye that is 
comparable to the human eye (Kompella et al., 2010; Zeiss, 2013). However, 
pharmacokinetic data require a large number of animals to be tested, consume a large 
amount of time and money, but still are currently essential for drug approval (Kompella et 
al., 2010). However, even between these species, ocular drug delivery can differ significantly 
(Proksch et al., 2009) and scaling or mathematical models can only account for these inter-
species differences up to some degree (Amrite et al., 2008). In general, the broader anatomy 
and physiology of the eye between different vertebrates is preserved, but there are still 
major differences and unique features that are the reason why animals cannot fully 
represent the human ophthalmic system (Zeiss, 2013). This is especially true for the retina 
and its macula where great differences can be observed. Mice, for instance, completely lack 
a macula (Zeiss, 2013). 
To conclude, limitations of animal experiments eventually include ethical issues, cost, and 
time-consumption and also major differences in anatomy or physiology compared to the 
human eye (Barar et al., 2009). Further, many countries today have legislative restrictions 
which confine the number of animals in experiments to be used. 
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1.3.3. Theoretical model systems 
Theoretical model systems include mathematical or computational models. These models 
are often designed to add value where traditional animal models show weaknesses, or to 
show ocular phenomena from a totally different perspective and are useful to test 
hypotheses (Roberts et al., 2016).  
The physiology of the healthy retina, retinal development, as well as the retina in a diseased 
state can be modeled in this regard (Roberts et al., 2016). For example, for disorders like 
retinitis pigmentosa or AMD, different models were established to test different hypotheses 
for disease progression or for potential treatment options (Roberts et al., 2016).  
In some cases, mathematical and computational models allow the extrapolation from one 
species to another, for example after testing the pharmacokinetic properties of a drug in an 
animal model (Amrite et al., 2008). Thus, the use of pharmacokinetic and pharmacodynamic 
mathematical models can speed up drug discovery and also drug development and might 
help to reduce the number of animals tested (del Amo et al., 2017). 
However, there is still a long way to go until detailed pathomechanisms as well as 
pharmacokinetic and pharmacodynamic aspects of a drug can be modeled without any living 
cell to be involved and future work will require cooperation of theorists and clinicians to find 
useful strategies in this regard. 
1.3.4. Explant culture 
The term explant culture is used for tissues sections that are removed using surgery and 
then kept in cell culture for limited periods of time depending on culture conditions like 
cultivation atmosphere or culture medium composition (Resau et al., 1991). Human or 
animal explant cultures of the eye have been used for retinal tissue (Johnson and Martin, 
2008; Orlans et al., 2018; Osborne et al., 2016; Valdés et al., 2016). They offer advantages 
for studies regarding differentiation, development, disease modeling like diabetic 
retinopathy, cell degeneration or therapy testing (Orlans et al., 2018; Osborne et al., 2016; 
Resau et al., 1991; Valdés et al., 2016). Most importantly, the usage of human donor tissue 
allows to overcome the limitations of interspecies differences.  
- 16 - 
 
 
However, the survival and long-term culture of these cells is often restricted to a few days 
and cells also might change their morphology and characteristics during ex vivo culture 
(Denk et al., 2015; Fernandez-Bueno et al., 2012; Rettinger and Wang, 2018). 
1.3.5. In vitro model systems 
An alternative model to in vivo and ex vivo models for a wide variety of applications can be 
traditional culture of cells in monolayers, either as primary cells or as immortalized cell lines. 
There are cell lines available for many different retinal cell types with the purpose of 
developmental or differentiation studies, toxicology or pharmacologic experiments, as well 
as disease modeling (Shafaie et al., 2016). 
One of the advantages that cell culture models offer, is a more defined experimental 
environment leading to more reproducible data (Barar et al., 2009; Kaur and Dufour, 2012). 
Moreover, problems of species-variability can be circumvented by using cells that originate 
from the desired species (Barar et al., 2009; Combes, 2004). Cell culture experiments in 
general, especially compared to in vivo experiments, are less expensive, have fewer legislative 
restrictions, are easier to handle and can still provide important insights regarding 
physiological or pathological functions (Kaur and Dufour, 2012) . 
Some of the most prominent examples of retinal cell lines are the immortalized RPE cell lines 
ARPE-19 and hTERT-RPE. But also other retinal cell lines like Müller glia or ganglion cell-
precursors are used in cell culture (Alge et al., 2006; Sarthy et al., 1998; Sayyad et al., 2017).   
Nevertheless, cell culture of primary cells or cell lines usually exhibit some limitations and 
disadvantages. Primary cells from human donors, like explant cultures, have limited 
availability and can only be cultivated for a few passages before changing their 
characteristics and passaging then is not possible anymore (Honegger, 2001). On the other 
hand, immortalized cell lines can be passaged for longer periods and can be easily and 
rapidly expanded, but this can lead to chromosomal changes or reduced characteristic-
marker expression (Honegger, 2001; Shafaie et al., 2016). 
Finally, cell monolayers in general do not show all characteristics that cells in a 3D meshwork 
would, starting from polarized expression of some proteins or communication and influence 
of neighboring cell types, for example via growth factor secretion (Shafaie et al., 2016). Also, 
mechanical forces and cell-cell as well as cell-matrix interactions can show differences 
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compared to 3D networks. Ultimately, the weakness of this system is still the absence of the 
natural local environment (Kaur and Dufour, 2012). 
 
1.3.6. Stem cell-based retinal model systems 
Besides the already mentioned possibilities of using immortalized cell lines or primary cells 
of retinal tissue, stem cells are another option and further advancement for in vitro cell 
culture experiments. Stem cell-based model systems can include animal or human cells and 
can make use of either multipotent or pluripotent stem cells which can be differentiated into 
retinal cell types to study development, physiological function or pharmacologic treatment 
options.  
Adult stem cells (endogenous stem cells) are cells that reside in a specific tissue of the adult 
body and are responsible for regeneration of specific cell types of this tissue (Montagnani et 
al., 2016). It should be noted here that endogenous stem cell candidates in the retina have 
been identified in different animal models but within different vertebrates, the capacity of 
endogenous stem cells for retinal regeneration can differ substantially (Achberger et al., 
2019a; Jeon and Oh, 2015). Even though it is possible to use some of these cell types (like 
Müller glia and RPE) as retinal progenitor-cell like cells in culture, they still show limited 
potency and therefore are only able to generate single cell types (Achberger et al., 2019a; 
Jeon and Oh, 2015).  
To achieve a complete retinal model with all cell types, this introduction of stem cell-based 
retinal models will focus rather on cell types with greater differentiation potential, which are 
pluripotent stem cells that were also used as starting material for retinal differentiation 
within this thesis. 
1.3.6.1. Pluripotent stem cells 
Pluripotent stem cells are (PSCs) defined by an unlimited capacity for self-renewal, and their 
ability to differentiate into cells of all three germ layers of the human body, i.e. ectoderm, 
endoderm and mesoderm. During the blastocyst stage of embryonic development, cells 
from the inner cell mass, also called the embryoblast, are pluripotent (Beddington and 
Robertson, 1989; Yu and Thomson, 2008). They are referred to as embryonic stem cells 
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(ESCs) and can be isolated from the inner cell mass (Martin, 1981). This was done for mouse 
cells in 1981 (Evans and Kaufman, 1981; Martin, 1981) and for human cells in 1998 
(Thomson et al., 1998). Using defined culture conditions, the described characteristics of 
ESCs can then also be maintained in vitro. Since this experimental method is possible, human 
ESCs have opened up new possibilities not only for therapeutic medicine but also for basic 
research and developmental questions. 
Because of their potential to be differentiated into any required cell type, transplantational 
approaches have been successfully conducted in many areas for example in cell replacement 
therapy for Morbus Parkinson or diabetes (Bjorklund et al., 2002; Kim et al., 2003; Lumelsky, 
2005; Sonntag et al., 2018). 
On the other hand, the applicability of ESCs and the necessity for in vitro fertilization and 
subsequent destruction of a human embryo, brings along many ethical concerns and turns 
this source of pluripotent stem cells very scarce and highly debated. Moreover, many 
countries today have extremely strict regulations for the usage of those cells and for 
example in Germany, generation of new ESC lines is not permitted (Bundesministerium der 
Justiz und für Verbraucherschutz, 2002). Further, the generated human ESC lines usually do 
not have patient- or disease-specific background, unless genetic-editing technologies are 
utilized. If transplanted cells with different genetic background would be used, immune 
rejection due to HLA differences will occur as a consequence (Drukker and Benvenisty, 
2004). 
Since the description and first generation of so called induced pluripotent stem cells (iPSCs) 
however, the tide had turned and many of the described limitation of ESCs could be 
circumvented. 
1.3.6.2. Induced pluripotent stem cells 
Since it was shown that somatic cells can be reprogrammed into pluripotent cells by fusing 
them with ESCs (Cowan et al., 2005; Tada et al., 2001), or by transferring their nucleus into 
oocytes (Wilmut et al., 1997), the question arose whether this was also possible using 
certain transcription factors. 
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In 2006, Yamanaka and Takahashi successfully used overexpression of the transcription 
factors OCT3/4, SOX2, c-MYC and KLF4 to reprogram mouse embryonic fibroblasts 
(Takahashi and Yamanaka, 2006) and later adult human fibroblasts (Takahashi et al., 2007). 
The generated cells which they named induced pluripotent stem cells (iPSCs), in fact showed 
the same morphology, surface markers, proliferation, gene expression- and epigenetic 
profile like ESCs (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). Moreover, the high 
activity of the enzyme telomerase, allowing the cell to constantly proliferate, is comparable 
to ESCs levels (Takahashi and Yamanaka, 2006). And, as previously mentioned for ESCs, iPSCs 
can be differentiated into all cells of the human body which can be shown in teratoma 
assays and using in vitro differentiation for all 3 three germ layers (Takahashi and Yamanaka, 
2006; Takahashi et al., 2007). 
The group of Yamanaka et al. initially used retroviral transfection of cells and first protocols 
required the cultivation on feeder cells that secrete growth factors and provide attachment 
for the reprogrammed cells (Takahashi and Yamanaka, 2006). 
Since then however, several advancements of their protocol have been achieved. 
Reprogramming and cultivation of the cells now is possible even without feeder cells on 
specialized coatings (Nakagawa et al., 2014). Some protocols avoid the integration of the 
proto-oncogen c-MYC to prevent tumor formation (Yu et al., 2007). The majority of newer 
protocols are designed to prevent integration into the genome, possibly inducing accidental 
mutagenesis, either by using viral vectors that do not integrate (for example the Sendai virus 
(Chen et al., 2013)), or using non-viral strategies of delivery like mRNA, miRNA or plasmid 
transfection (Malik and Rao, 2013; Okita et al., 2008). 
1.3.6.3. 2D retina models from stem cells 
Although a variety of differentiation protocols exist, that allow the generation of retinal cell 
types from adult or pluripotent stem cells, these models usually only feature one cell type in 
two dimensions. This means that neither the complex interplay and communication with 
surrounding cell types is represented, nor the actual physiological arrangement in three 
dimensions. Especially in the retina, where different neuronal and glial cell types are 
connected to interact, a 2D approach will most certainly not be suitable as a physiological 
model system. This problem, not only playing a role in retinal models, but in models of any 
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organ, could be overcome by the generation of 3D models that will be discussed in the next 
section. 
1.3.6.4. Advanced 3D in vitro culture system: Organoids 
The term “organoid” refers to in vitro structures that are 3-dimensional and can be 
generated either from progenitor cells or from pluripotent stem cell types (Bartfeld and 
Clevers, 2017). Most important, they are characterized by a functionality and morphology 
that closely mimics the organ since these cells are arranged more similar to how they would 
be arranged in vivo. Interestingly, these organ-like structures often self-organize and carry 
multiple cell types which is a key differentiation point compared to traditional adherent 
culture systems using cell lines (Achberger et al., 2019a; Lancaster and Knoblich, 2014). 
In 2008, first organoids were generated as cortical spheres from mouse embryonic stem cells 
in suspension (Eiraku et al., 2008). Of note, this first report already used self-organization of 
cells and highlights that spatial and temporal aspects of organ development can be 
recapitulated with these aggregates (Eiraku et al., 2008). 
Since then, organoids have been generated from human iPSCs and have been developed as 
model system for almost every tissue, such as pancreas (Hohwieler et al., 2017; Huang et al., 
2015), liver (Takebe et al., 2013), brain (Lancaster et al., 2013), cornea (Foster et al., 2017; 
Susaimanickam et al., 2017), as well as retina (Meyer et al., 2009; Zhong et al., 2014). 
Organoid technology not only holds great potential because of the many different tissues 
that can be generated but also, since organoid generation is possible virtually from every 
individual. This allows modeling of a disease in the dish and moreover, potential 
transplantation approaches, drug discovery and personalized drug treatment are possible 
(Bartfeld and Clevers, 2017). The first case, where organoids were used successfully for a 
personalized medicine approach was in 2015 when a cystic fibrosis patient was treated 
based on drug-screening results gained using primary intestinal organoids generated from 
intestinal adult stem cells of the patient (Dekkers et al., 2013; Saini, 2016). 
In addition, pluripotent stem cell-derived organoids have now found applications in drug-
screening and toxicity testing. For example kidney and liver-organoids can be tested in vitro 
for superior judgement of side-effects of systemic drugs or environmental toxins (Forsythe 
et al., 2018; Takasato et al., 2015).  
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Since the presented work involves usage of retinal organoids, different protocols for 
generation of this organoid type will be introduced in the following, combined with current 
limitations of this model system. 
1.3.6.5. Retinal organoids 
The first report of retinal organoids using human ESCs and iPSCs showed the generation of 
retinal spheres in a stepwise differentiation process that was able to mimic normal 
development and generated retinal progenitors as well as some retina-specific cell types 
(Achberger et al., 2019a; Meyer et al., 2009). 
The protocol made use of the fact that human PSCs will develop into anterior neuroepithelial 
cells under serum-free conditions in proneural medium (Meyer et al., 2009). Consequently, 
the retinal lineage differentiation seems to be the “default” state if no other extrinsic cues 
are present. This phenomenon is known as the “default model” also described in other 
publications (Kamiya et al., 2011; Muñoz-Sanjuán and Brivanlou, 2002; Smukler et al., 2006). 
Today, there are several protocols for generation of retinal organoids that mainly differ with 
regard to adherence and suspension steps. Protocols by the group of Sasai et al. for instance, 
used 3D suspension for every step of the differentiation from embryoid bodies (EBs) up to an 
optic vesicle and later, an optic cup-like stage (Eiraku et al., 2011; Nakano et al., 2012). 
On the other hand, protocols using a combination of 2D and 3D differentiation during 
organoid formation are described by Zhong et al. (Zhong et al., 2014) and Meyer et al. 
(Meyer et al., 2011) and were used as a basis for our retinal organoid differentiation 
protocol. The initial steps of the protocol, during which an undirected neural differentiation 
is performed, take place as adherent steps after plating of EBs on coated dishes. As soon as 
eye fields are formed in those adherent cultures, they are manually selected and detached 
and will self-organize in suspension to form retinal organoids and can be kept in suspension 
(Meyer et al., 2011; Zhong et al., 2014). If specific RPE-enriched differentiation is  
intended, they can later be plated again (Ohlemacher et al., 2016). These protocols however, 
do not aim to form optic cups, but will yield optic vesicle-like structures (Meyer et al., 2011; 
Zhong et al., 2014).  
In this context, the ration of RPE vs. neural retina in cultures seems to play an important role 
in whether or not optic cups are formed (Nakano et al., 2012). Therefore, the optic cup-
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protocols use Wnt signaling to improve MITF expression and RPE differentiation to achieve 
the correct ratio (Nakano et al., 2012). Even though it might seem that optic cups represent 
a more mature stage and show the correct apposition of RPE vs. neural retina, they lack a 
full retinal layering compared to optic vesicle-protocols and can therefore be regarded as 
less mature (Achberger et al., 2019a; Nakano et al., 2012). 
To conclude, while the first protocols published only showed some retinal cell types, still 
lacking complex retinal layering, the differentiation process was continuously improved in 
several protocols and today, it is possible to generate retinal organoids that show all major 
retinal neurons and also Müller glia cells (Achberger et al., 2019a). 
Further, retinal organoids show retinal layering including an outer and inner nuclear layer, 
ganglion cell layer, as well as a synaptic outer plexiform layer. Furthermore, light-
responsiveness of the photoreceptor cells could be shown as a functional proof of maturity 
(Zhong et al., 2014).  
Retinal organoids have found broad applications in disease modeling for example to study 
glaucoma, or Leber congenital amaurosis (Ohlemacher et al., 2016; Parfitt et al., 2016) but 
they have also been used for toxicology screenings and pharmacological studies (Ito et al., 
2017; Jin et al., 2011). 
 
However, the organoid system as retinal model still features some specific limitations. 
First, organoids often still miss tissue-tissue interactions and contact with surrounding 
parenchymal tissues that is essential for a normal organ function in vivo (Bhatia and Ingber, 
2014). For retinal organoids, this means an absence of blood vessels or immune cells in the 
organoid (Clevers, 2016). Further, cell types that would normally integrate from other 
tissues like cells that originate from the CNS and mesodermal cell types are missing 
(Achberger et al., 2019a).  
Second, organoids usually show a high variability in size and shape mainly due to variability 
in media supply in the standard culture dish. Cell degeneration, low maturity (for example of 
photoreceptor outer segments of retinal organoids), low throughput and low reproducibility 
are some major drawbacks of using organoids as a model system (Achberger et al., 2019a; 
Takebe et al., 2017).   
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Third, organoids in standard dish culture are difficult to be analyzed for functionality, 
partially because cells cannot be kept in a constant position for long-term analysis and 
partially because cells in the inside of the sphere are usually hard to reach for visual or 
functional monitoring (Bhatia and Ingber, 2014). 
Consequently, it seems necessary to improve the current retinal organoid system with new 
options for cultivation. 
1.3.7. Microfluidic organ-on-a-chip systems 
As described in the previous section, one of the major limitations of the organoid system is 
centered around the way they are cultured. Therefore, new culture systems aim to improve 
this aspect. 
“Organ-on-a-chip” (OoC) systems are microfluidic devices usually made of biocompatible 
plastics that allow the cultivation of cells or cell sheets with the goal of achieving a more 
organ-like physiology (Bhatia and Ingber, 2014). They can be generated using a combination 
of different microfabrication methods including, for example, photolithograph, replica 
molding and microcontact printing (Huh et al., 2011). The material used in most cases today 
is polydimethylsiloxane (PDMS) which is inexpensive, easy to handle, transparent and has 
high gas permeability, as opposed to other materials like silicon, glass or plastic that require 
additional oxygenation (Huh et al., 2011). 
Microfluidic systems include microscopic structures to simulate the cells natural 
environment in the human body, and are often used to recapitulate the multicellular 
architecture of a tissue, cell-cell as well as cell-matrix interactions (Bhatia and Ingber, 2014; 
Huh et al., 2010; Takebe et al., 2017). 
Furthermore, they usually include microchannels for a controlled and steady fluid flow to 
simulate the body’s vascular perfusion for a better oxygen and nutrient supply (Bhatia and 
Ingber, 2014). Different levels of complexity of these systems can be designed, including one 
or several cells types in different chambers and additionally, one or several microchannels 
that can be separated by porous membranes or substrates for simulation of a tissue barrier 
function. 
In this way, microfluidic systems increase reproducibility since they offer control over many 
parameters and, due to a more physiological culture, have the potential to increase maturity 
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and survival of the cultured cells or tissue (Takebe et al., 2017). Moreover, physiological 
stimuli can be integrated into the chip system, for example chemical or electrical 
stimulation, mechanical movements or stretching (Huh et al., 2012). 
Another important aspect is that these chips can be used as a screening platform for in vitro 
analyses, for example they enable real-time imaging, or in the case of neurons, 
electrophysiological monitoring as well as other tests of functionality with the help of 
integrated microsensors (Bhatia and Ingber, 2014; Huh et al., 2011).  
Consequently, microfluidic organ-on-a-chip systems can produce a level of simulated organ 
functionality that cannot be achieved using standard 2D or 3D culture systems (Bhatia and 
Ingber, 2014; Huh et al., 2011). Concerning drug discovery and toxicity testing, these systems 
have the potential to serve as a platform for a near-physiological testing that can not only 
help reduce the number of animals to be tested and therefore make the process cheaper 
and faster, but it might also offer totally new options and insights when no suitable other 
model is available (Huh et al., 2010; Mathur et al., 2015; Viravaidya and Shuler, 2008). 
Especially the combination of the organoid technology with the organ-on-a-chip system 
holds the promise of a synergistic engineering approach, potentially leading to enhanced 
fidelity, reproducibility, maturity and higher throughput (Takebe et al., 2017). 
Organ-on-a-chip systems have been developed for a variety of cell types and for modeling of 
different organs, including lung (Huh et al., 2010), heart (Mathur et al., 2015, 2016), liver 
(Carraro et al., 2008), cornea (Puleo et al., 2009), as well as retina (Dodson et al., 2015a; 
Mishra et al., 2015; Su et al., 2015). Existing microfluidic retina-on-a-chip models will be 
described in greater detail within the next section. 
1.3.7.1. Existing microfluidic retina-on-a-chip systems  
There are several retina-on-a-chip models available that were designed to replicate and 
observe the effects of retinal cell replacement after implantation of retinal progenitor cells 
(Haderspeck et al., 2019). Such microfluidic systems might help to improve the outcomes of 
regenerative cell transplantation in disorders that involve retinal degeneration like age-
related macular degeneration or retinitis pigmentosa. 
A chip designed for retinal synaptic regeneration by the group of Su et al. was developed by 
integrating two microchambers connected by a number of microchannels (Su et al., 2015). 
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This allows to analyze axonal outgrowth between two different retinal cell populations 
seeded into the cell chambers and thus, to observe synaptogenesis and factors that can help 
to improve retinal regeneration (Su et al., 2015). 
Another chip integrating retinal cells was designed to analyze cell migration patterns after 
transplantation (Mishra et al., 2015). This system, called µRetina, was rather focused on 
replication of the geometric properties of the human and the mouse retina, respectively and 
was realized by an arch-shaped chamber for cell cultivation (Mishra et al., 2015). 
While these two systems can help to find useful factors to improve cell transplantation and 
retinal axon outgrowth, they are very limited for this very specific application. They only 
include some retinal cell types and are not able to replicate more complex 
pathophysiological questions and the sophisticated human retinal architecture.  
On the other hand, there are also retina-on-a-chip systems that include whole organs or 
tissue slices like the chip developed by Dodson et al. (Dodson et al., 2015a). Mouse retinal 
explants can be cultivated ex vivo allowing the testing of different chemical substances 
(Dodson et al., 2015a). As mentioned before for other retinal explants, in this system the 
viability of cells and the usability of human material is limited.
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2. Aim of this thesis 
The aim of this thesis was to generate a microphysiological retina-on-a-chip system by 
integrating retinal organoids as well as RPE derived from human induced pluripotent stem 
cells (iPSCs) into a microfluidic chip system.  
In a first step, retinal organoids had to be differentiated from human iPSCs and retinal 
pigment epithelium (RPE) cells had to be cultured as monolayers. Next, different variants of 
a microfluidic chip system had to be developed to test the integration of the organoid as 
well as the RPE, and further, to show that the respective cell types are still expressed and 
able to survive in the system. Characteristic marker expression was shown on protein level 
using immunohistochemistry, and on mRNA level using qRT-PCR. Morphological features 
were analyzed with electron microscopy. 
In a second step, a co-culture retina-on-a-chip (RoC) system was developed that allowed the 
integration of retinal organoid as well as RPE to be able to cultivate them in a physiological 
manner. To test whether the RoC actually showed retinal functionality, some key retinal 
features were analyzed, including phagocytosis of photoreceptor outer segments and 
improvement of outgrowth of photoreceptors outer segments. 
Finally, as a proof-of-principle study, the suitability of the retina-on-a-chip system as drug 
testing device was analyzed. Chemicals with known retinopathic side-effects were tested 
and effects were monitored.
- 27 - 
 
 
3. Material 
3.1. Machines, tools and labware 
Table 1: List of machines and tools 
Machine  Company 
Analytical Balance  
BP2218-0CE  
Sartorius, Göttingen, Germany 
BioMark HD  Fluidigm, South San Francisco, CA, USA  
BioTek ELx800 Absorbance Microplate 
Reader 
BioTek Instruments, Winooski, USA 
Cryostat, Microm HM 560  Thermo Fischer Scientific, Waltham, MA, USA  
Evos FL Cell Imaging System Thermo Fischer Scientific, Waltham, MA, USA  
Fluidigm BioMark HD Fluidigm, South San Francisco, CA, USA  
Freezer -20°C Liebherr, Biberach, Germany  
Freezer -80°C Thermo Fischer Scientific, Waltham, MA, USA  
Fridge 4°C  Liebherr, Biberach, Germany  
Heraeus Megafuge 16 Centrifuge Thermo Fischer Scientific, Waltham, MA, USA 
Heraeus Fresco 17 Centrifuge Thermo Fischer Scientific, Waltham, MA, USA 
Ice machine, AF103  Scotsman, Great Blakenham, UK  
Incubator 37°C, Heracell 240i  Thermo Fischer Scientific, Waltham, MA, USA  
Legato 210 pump  KD Scientific, Holliston, MA, USA  
Microscope (Axioskop 2 mot plus,  
Primo Vert)  
Zeiss, Oberkochen, Germany  
Multipipette Stream Eppendorf, Hamburg, Germany 
NanoPhotometer P330  Implen, München, Germany  
Nitrogen Tank, CryoPlus 2  Thermo Fischer Scientific, Waltham, MA, USA  
PCR Thermocycler, peqStar  Peqlab Biotechnologie, Erlangen, Germany  
Pipette research plus (2.5 μl ,10 μl, 100 μl, 
200 μl, 1000 μl, 5 ml) 
Eppendorf, Hamburg, Germany 
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Pipette F1 Clip-Tip (10 μl, 100 μl, 1000 μl) Eppendorf, Hamburg, Germany 
Pipettus Hirschmann, Eberstadt, Germany 
Reichert Ultracut S  Leica, Wetzlar, Germany  
StepOnePlus real-time PCR systems  Thermo Fischer Scientific, Waltham, MA, USA  
Sterile Bench, MSC-Advantage  Thermo Fischer Scientific, Waltham, MA, USA  
SU8 developer  Micro Resist Technology, Berlin, Germany  
Ultra-Fine-Clipper-Scissors-II  Fine Science Tools, Heidelberg, Germany  
 
Upright fluorescence microscope BX50WI Olympus, Tokio, Japan  
UV developer Quantum ST4  Vilber Lourmat, Eberhardzell, Germany  
Vacuum Pump, Integra Vacusafe  Integra Biosciences, Biebertal, Germany  
Vortexer  Bender+ Hobein, Zürich, Switzerland  
Water bath, Lab Line waterbath  Thermo Fischer Scientific, Waltham, MA, USA  
Zeiss EM 900 transmission electron 
microscope  
Zeiss, Jena, Germany  
 
Table 2: List of labware 
Labware Company 
6-, 12-, 24- well-plates (Tissue treated, Non 
treated)  
Becton Dickinson, New York, NY, USA  
96 Well-V-shaped culture plates  Sarstedt, Nümbrecht, Germany  
Cell scraper  Thermo Fischer Scientific, Waltham, MA, USA  
Cell strainer 70 μm  Becton Dickinson, New York, NY, USA  
Coverslips, Menzel (24 mm x 24 mm, 24 
mm x 40 mm)  
Thermo Fischer Scientific, Waltham, MA, USA  
Fluidigm 96.96 Dynamic Array IFC  Fluidigm, South San Francisco, CA, USA  
Dako pen  Dako, Hamburg, Germany  
Gloves Peha-Soft nitrile  Hartmann, Heidenheim, Germany  
PET membranes  Sabeu, Northeim, Germany  
Petri dishes (10 cm, 6 cm)  Greiner Bio-One, Frickenhausen, Germany  
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Pipette tips (10 μl, 100 μl, 200 μl, 1 ml, 5 
ml)  
Eppendorf, Hamburg, Germany  
Pipettus Hirschmann, Eberstadt, Germany 
QiaShredder  Qiagen, Hilden, Germany  
Reaction tubes (15 ml, 50 ml)  Becton Dickinson, New York, NY, USA  
Reaction tubes small (0.5 ml, 1.5 ml, 2.0 
ml)  
Sarstedt, Nümbrecht, Germany  
Serological Pipettes (5 ml, 10 ml, 25 ml, 50 
ml) 
Sarstedt, Nümbrecht, Germany 
Sterile filters (0.22 μm, 0.45 μm)  Merck Millipore, Darmstadt, Germany  
Super FrostPlus object slides  R. Langenbrinck, Emmendingen, Germany  
Syringes BD Plastipak 50 ml  Thermo Fischer Scientific, Waltham, MA, USA 
Syringes, BD Syringe with Luer-Lok Tips (5 
ml, 10 ml, 20 ml) 
Thermo Fischer Scientific, Waltham, MA, USA 
Syringes, BD 1 ml Insulin Syringe with Slip 
Tip 
Thermo Fischer Scientific, Waltham, MA, USA 
T25-flasks (Culture treated)  Greiner Bio-One, Frickenhausen, Germany  
 
3.2. Media, chemicals, supplements 
Table 3: List of cell culture media 
Machine  Company 
Antibiotic-antimycotic 100 x liquid  Thermo Fischer Scientific, Waltham, MA, USA  
CryoStem  Biological Industries, Beit Haemek, Israel  
DMEM, high glucose  Thermo Fischer Scientific, Waltham, MA, USA  
DMEM/F12 + GlutaMAX  Thermo Fischer Scientific, Waltham, MA, USA  
Fetal bovine serum (FBS)  Thermo Fischer Scientific, Waltham, MA, USA  
GlutaMax 100 x liquid  Thermo Fischer Scientific, Waltham, MA, USA  
KnockOut -DMEM  Thermo Fischer Scientific, Waltham, MA, USA  
KnockOut serum replacement  Thermo Fischer Scientific, Waltham, MA, USA  
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Non-essential amino acids  Thermo Fischer Scientific, Waltham, MA, USA  
Normal donkey serum (NDS)  Sigma-Aldrich, St. Louis, MO, USA  
OptiMEM  Thermo Fischer Scientific, Waltham, MA, USA  
PeproGrow hESC embryonic stem cell 
media  
PeproTech, Hamburg, Germany  
Phosphate-buffered saline (PBS) w/o 
magnesium and calcium  
Thermo Fischer Scientific, Waltham, MA, USA  
Synth-A-Freeze cryopreservation medium  Thermo Fischer Scientific, Waltham, MA, USA  
 
Table 4: List of chemicals and supplements 
Chemical  Company 
9-cis-retinal  Sigma-Aldrich, St. Louis, MO, USA  
Activin A  Cell Guidance Systems LLC, St. Louis, MO, 
USA  
Agarose  AppliChem, Darmstadt, Germany  
All-trans-retinoic acid  Sigma-Aldrich, St. Louis, MO, USA  
Apotransferrin  Serologicals, Atlanta, GA, USA  
Araldite resin  Serva, Heidelberg, Germany  
B-27 without vitamin A  Thermo Fischer Scientific, Waltham, MA, USA  
Bis-[3-trimethoxysilypropyl]amine  Sigma-Aldrich, St. Louis, MO, USA  
(-)- Blebbistatin  Sigma-Aldrich, St. Louis, MO, USA  
Bovine insulin  Sigma-Aldrich, St. Louis, MO, USA  
Bovine outer segments InVision BioResources, Seattle, WA, USA 
Chemically defined lipid (CDL) concentrate  Thermo Fischer Scientific, Waltham, MA, USA  
Chlorotrimethylsilane  Sigma-Aldrich, St. Louis, MO, USA  
Chloroquine Sigma-Aldrich, St. Louis, MO, USA 
Collagen IV  Sigma-Aldrich, St. Louis, MO, USA  
DAPI Thermo Fischer Scientific, Waltham, MA, USA 
Dorsomorphin dihydrochloride  Tocris Bio-Techne, Wiesbaden-Nordenstadt, 
Germany  
- 31 - 
 
 
Ethanol  Serva, Heidelberg, Germany  
Gentamicin Sigma-Aldrich, St. Louis, MO, USA 
Glutaraldehyde  Electron Microscopy Sciences, Munich, 
Germany  
Heparin sodium salt  Sigma-Aldrich, St. Louis, MO, USA  
Human recombinant EGF  Cell Guidance Systems LLC, St. Louis, MO, 
USA  
Human recombinant FGF-2  Cell Guidance Systems LLC, St. Louis, MO, 
USA  
Human serum albumin (HSA)  Biological Industries, Cromwell, CT, USA  
HOECHST 33342 Thermo Fischer Scientific, Waltham, MA, USA  
HyStem-C- hydrogel  EsiBio, Alameda, CA, USA  
Isopropanol  VWR, Radnor, PA, USA  
ITS  BD Bioscience, San Jose, CA, USA  
L-Ascorbic acid  Sigma-Aldrich, St. Louis, MO, USA  
Lenti-X concentrator  Takara Bio, Kusatsu, Japan  
Paraformaldehyd  Roth, Karlsruhe, Germany  
Polybrene (Hexadimethrine bromide)  Sigma-Aldrich, St. Louis, MO, USA  
Polydimethylsiloxane (PDMS)  
Sylgard 184  
Dow Corning, Midland, MI, USA  
Polyethylenimine  Polysciences, Warrington, PA, USA  
Progesteron  Sigma-Aldrich, St. Louis, MO, USA  
ProLong gold antifade mountant with DAPI  Thermo Fischer Scientific, Waltham, MA, USA  
Propidium iodide Sigma-Aldrich, St. Louis, MO, USA 
Putrescine dihydrochlorid  Sigma-Aldrich, St. Louis, MO, USA  
Rock-inhibitor Y-27632  Ascent Scientific, Avonmouth, UK  
Saponin Merck Millipore, Darmstadt, Germany  
Sodium cacodylate buffer, pH 7.4  Electron Microscopy Sciences, Munich, 
Germany  
SU8-50 photoresist  
 
MicroChem, Westborough, MA, USA  
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Sucrose  
 
Roth, Karlsruhe, Germany  
Taurine  
 
Sigma-Aldrich, St. Louis, MO, USA  
TGFβ1 
 
Cell Guidance Systems LLC, St. Louis, MO, 
USA  
Tissue-Tek O.C.T. compound  
 
Sakura, Alphen aan den Rijn, NL  
Triton X-100 
 
Roth, Karlsruhe, Germany  
Uranyl acetate  
 
Serva, Heidelberg, Germany  
 
Table 5: List of cell culture coatings 
Coating  Company 
Collagen IV  Sigma-Aldrich, St. Louis, MO, USA  
Laminin  Roche, Basel, Switzerland  
Matrigel, hESC-Qualified  Corning, New York, NY, USA  
Matrigel, Growth factor reduced  Corning, New York, NY, USA  
Poly-L-ornithine  Sigma-Aldrich, St. Louis, MO, USA  
 
 
Table 6: List of enzymes 
Enzyme Company 
AccuMax  Sigma-Aldrich, St. Louis, MO, USA  
Dispase  Stem Cell Technologies, Vancouver, Canada  
TrypLE Express  Thermo Fischer Scientific, Waltham, MA, USA  
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3.3. Antibodies and vectors 
Table 7: List of primary antibodies 
Antibody Dilution Company 
CASP3 1:200 Thermo Fisher Scientific, USA 
EEA1  1:500 eBioscience, Thermo Fisher Scientific, 
USA 
EZRIN  1:200 Cell Signaling, USA 
LAMP2  1:50 Santa Cruz Biotechnology, USA 
Melanoma gp100  1:100 Abcam, USA 
MITF  1:500 Exalpha Biologicals, USA 
Phalloidin Alexa Fluor 647 1:500 Thermo Fisher Scientific, USA 
PAX6  1:100 Santa Cruz Biotechnology, USA 
PNA lectin-Alexa 
Fluor 568 or 647 
20 mg/ml Thermo Fisher Scientific, USA 
Rhodopsin  1:200 Santa Cruz Biotechnology, USA 
ROM1 1:200 Proteintech, USA 
ZO1 1:100 Thermo Fisher Scientific, USA 
 
Table 8: List of secondary antibodies 
Enzyme Dilution Company 
Alexa Fluor 488 Donkey anti mouse IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 568 Donkey anti mouse IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 647 Donkey anti mouse IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 488 Donkey anti goat IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 568 Donkey anti goat IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 647 Donkey anti goat IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 488 Donkey anti rabbit IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 568 Donkey anti rabbit IgG  1:1000 Abcam, Cambridge, UK 
Alexa Fluor 647 Donkey anti rabbit IgG  1:1000 Abcam, Cambridge, UK 
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Table 9: List of plasmids 
Plasmid Origin 
pJG-IRPB-eGFP Vector 
 
Gift from Deepak Lamba & Thomas Reh 
(Lamba et al., 2010)  
psPAX2  
lentiviral packing plasmid 
gift from Didier Trono, Addgene plasmid # 
12260 
pMD2.G  
envelope expressing plasmid  
gift from Didier Trono, Addgene plasmid # 
12259 
 
3.4. Kits and assays 
 
Table 10: List of kits 
Kit Company 
CellLight Early Endosomes-GFP, 
BacMam 2.0 
Thermo Fischer Scientific, Waltham, MA, USA 
PreAmp Master Mix Fluidigm, San Fransisco, USA  
RNeasy Plus Micro Kit Qiagen, Hilden, Germany 
RNeasy Plus Mini Kit Qiagen, Hilden, Germany 
VEGF-A Human ELISA Kit Thermo Fischer Scientific, Waltham, MA, USA 
 
Table 11: List of Taqman assays for Fluidigm.   
All Taqman assay were purchased from Thermo Fisher Scientific, Waltham, USA 
Gene Companies’ article number 
ANXA4  Hs00154040_m1  
BEST1           Hs04397293_m1           
CRX  Hs00230899_m1  
GAPDH Hs99999905_m1 
GLUL (GLU1) Hs00365928_g1  
GNAT1  Hs00181100_m1  
GNGT1  Hs00184207_m1 
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HMBS Hs00609297_m1 
LHX2 Hs00180351_m1    
MITF Hs01117294_m1       
NRL  Hs00172997_m1  
PMEL (GP100) Hs00173854_m1      
PRKCA (PKCA) Hs00925193_m1 
PROX1  Hs00896294_m1  
PRPH2 (PERIPHERIN2) Hs00165616_m1 
RAX (RX) Hs00429459_m1  
RPE65 Hs01071462_m1    
SERPINF1 (PEDF) Hs01106937_m1 
TJP1 (ZO1) Hs01551861_m1   
VSX2 (CHX10) Hs01584047_m1  
 
3.5. Software 
Table 12: List of software 
Software Company 
Adobe Illustrator Adobe Systems Software Ireland Limited, 
Dublin, Republic of Ireland 
AxioVision SE64 Rel 4.9  Carl Zeiss AG, Oberkochen, Germany 
Fluidigm Real-Time PCR Analysis Software 
v.3.0.2.  
Fluidigm, San Fransisco, USA  
Gen5 Microplate Reading & Data Analysis BioTek Instruments, Winooski, USA 
ImageJ v1.51w  https://imagej.nih.gov/  
Microsoft Office  Microsoft Corporation, Redmond, USA  
Prism 8.2.0 Graphpad Software, La Jolla, UA  
StepOne Software V 2.3  Thermo Fisher Scientific, Waltham, USA  
ZEN Carl Zeiss AG, Oberkochen, Germany  
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4. Methods  
4.1. Cell culture methods 
Cultivation of stem cells as well as of derived differentiation products was performed under 
sterile conditions at a sterile bench. For medium change, cultivation media were heated to 
37°C before usage. Standard incubation was performed at 37°C in an incubator with 5% CO2 
and 5% O2 for stem cell cultivation and 5% CO2 and 20% O2 for retinal organoid (RO) and 
retinal pigmented epithelium (RPE) or chip cultivation. 
Stem cells used in this work were human induced pluripotent stem cells (hiPSCs) that have 
been derived from keratinocytes of plucked human hair roots. Written consent of the 
donating persons was documented. The experiments were performed in accordance with 
the Helsinki convention and approval of the Ethical Committee was granted (Nr. 
678/2017BO2) at the Eberhard Karls University Tübingen.  
4.1.1. Human induced pluripotent stem cell culture 
Starting material for this work were hiPSCs derived from keratinocytes from healthy 
individuals as previously described (Linta et al., 2012). Briefly, lentiviral vectors were used to 
deliver a pluripotency cassette carrying the 4 pluripotency factors: OCT4, SOX2, KLF4 and c-
MYC. Reprogramming of keratinocytes was performed on mouse embryonic fibroblasts as 
feeder cells. Growing colonies of hiPSCs were transferred and kept in feeder-free conditions. 
The hiPSCs were characterized for their stem cell characteristics as described before using 
immunohistochemistry to stain for pluripotency markers and by performing germ layer 
differentiation to proof the ability of hiPSCs to generate cells from ectoderm, endoderm as 
well as mesoderm. 
For standard cultivation, hiPSCs were grown as colonies on matrigel coating in 6-well plates. 
For passaging, 1 dense well of cells was detached by washing once with PBS, adding 500 μl 
stem-cell dispase (diluted in DMEM/F12 1:6), incubating for 1 min at room temperature and 
washing again twice with PBS. Then, 1 ml of FTDA-medium was added to the well and cell 
colonies were detached gently by using a cell scraper. The cells were then transferred onto 
freshly coated wells after incubation with matrigel for 1 h at 37°C.  
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The passing usually was performed once a week and cells were split 1:5 or 1:6 onto new 6-
wells. Cells were then incubated at 37°C, 5% CO2 and 5% O2 and medium. Medium was 
changed daily with 1.5 ml FTDA medium. 
 
FTDA medium: 
 
• DMEM/F12+GlutaMAX 
• 1:100 Human serum albumin (HSA) 
• 1:100 Chemically defined lipids (CDL) 
• 1x Antibiotic-Antimycotic (100x) (Anti-Anti) 
• 1:1000 Insulin-transferrin-selenium (ITS) 
• 10 ng/ml FGF2 
• 5 ng/ml Activin A 
• 0.5 ng/ml TGFβ1 
• 50 nM Dorsomorphin 
4.1.1.1. Freezing and thawing of hiPSCs 
For cryo-freezing, hiPSC colonies were allowed to grow 80% dense and colonies were 
detached using stem-cell dispase as described before for the procedure of passaging. After 
stopping the reaction, cell colonies were collected in FTDA medium and centrifuged at 1500 
rpm, 2 min. Supernatant was discarded, and the cell pellet was carefully dissociated in 0.8 
ml/well CryoStem and transferred to the corresponding number of cryovials. Attention was 
paid that cell colonies were not fully dissociated. Cryovials were moved into a cryo-container 
with isopropanol at -80°C and on the next day, moved to liquid nitrogen storage at -196°C 
for long-term freezing. 
For thawing of hiPSCs, cryovials were quickly heated in a water bath of 37°C and then gently 
transferred to pre-warmed FTDA-medium in a 15 ml-tube for centrifugation at 1500 rpm, 2 
min. The cell pellet of one cryovial was resuspended in 1.5 ml FTDA-medium and distributed 
onto a matrigel pre-coated well of a 6-well plate. 
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4.1.2. Differentiation protocols 
4.1.2.1. Retinal organoid differentiation protocol 
The differentiation protocol for generation of retinal organoid (ROs) was adapted from the 
protocol by Zhong et al. (Zhong et al., 2014) with some processes modified. To initiate 
differentiation (defined as day 0), embryoid bodies (EBs) were generated by detaching and 
dissociating 2.88*106 hiPSCs of a 6-well plate using treatment with TrypLE for 6-8 min at 
37°C and by stopping the reaction with PeproGrow hESC embryonic stem cell medium. After 
centrifugation (1500 rpm, 2 min), the cell pellet was resuspended in PeproGrow hESC 
embryonic stem cell medium supplemented with 1% Antibiotics- Antimycotics, 10 μM Y-
27632, 10 μM blebbistatin. The cells in suspension were distributed in a volume of 100 
μl/well on a v-shaped 96-well plate and centrifuged again (400 g, 4 min) to allow re-
aggregation of cells. Plates were then cultivated at 37°C, 5% CO2 and 20% O2.  
On the following day (defined as day 1 of differentiation), 80% of the medium was replaced 
with a neural induction medium (N2-medium, see below). On day 4, medium was again 
changed with N2-medium. 
On day 7, EBs were collected carefully from the 96-well plate and then plated equally onto a 
6-well plate coated with growth-factor reduced matrigel for 1 h at 37°C. Approximately 32 
EBs were plated per well of the 6-well plate. Medium was then changed daily with 1.5 ml of 
N2-medium/well.  
On day 16, cultivation medium was switched from N2 to a B27-based retinal differentiation 
medium (BRDM, see below) and changed daily with 1.5 ml of BRDM-medium. 
On day 24, retinal fields were detached: First, medium was changed with fresh BRDM. Then, 
retinal field areas were identified morphologically and detached with a 10 μl pipette tip 
under a bright-field microscope. Detached cell clusters were collected in 10 cm-dishes 
(uncoated), medium was filled up to 10 ml and 10 μM Y-27632 was added overnight. 
Cultivation medium was changed twice a week with BRDM-medium. For each medium 
change, cells were allowed to sink to the bottom of the dish, before half of the medium was 
replaced. 
When formation of the spheres was completed, ROs were manually sorted from non-retinal 
spheres by their morphological appearance. If non-retinal cells were attached to a retinal 
part, the parts were manually isolated using Ultra-Fine-Clipper-Scissors-II under the bright-
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field microscope. Retinal spheres were collected, and morphology was checked regularly 
before medium change. 
From day 40, the cultivation medium was switched to BRDM supplemented with 10% FBS 
and 100 μM taurine and changed twice a week. 
From day 70, the medium was additionally supplemented with 1 μM retinoic acid which was 
reduced to 0.5 μM retinoic acid from day 100 onwards. 
After day 190, retinoid acid was removed, but addition of FBS and taurine was continued. 
 
N2-medium: 
• DMEM/F12 + GlutaMAX supplement 
• 24 nM sodium selenite 
• 16 nM progesterone 
• 80 μg/ml human apotransferrin 
• 20 μg/ml human recombinant insulin 
• 88 μM putrescin 
• 1x non-essential amino acids (100x) 
• 1x antibiotics-antimycotics (100x) 
 
BRDM-medium: 
• DMEM/F12 + GlutaMAX supplement   :   DMEM, high glucose     (1:1) 
• 2% B27 (w/o vitamin A) 
• 1x non-essential amino acids (100x) 
• 1x antibiotics-antimycotics (100x) 
4.1.2.2. Retinal pigment epithelium differentiation protocol 
Retinal pigment epithelium (RPE) cells were derived from RO-differentiation as a by-product 
and cultivated according to protocols by Zhong et al. (Zhong et al., 2014) and Ohlemacher et 
al. (Ohlemacher et al., 2015) with some modifications. 
Retinal spheres in suspension (as described above) after day 40 can show parts which 
become increasingly pigmented over time. These pigmented areas were manually dissected 
from non-pigmented retinal areas using Ultra-Fine-Clipper-Scissors-II and collected in a 1.5 
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ml Eppendorf tube. After washing with PBS, cell aggregates were treated for 90 min with 
AccuMax at 37°C at 5% CO2 for dissociation into single cells. To improve dissociation, every 
30 min cells were carefully resuspended. After complete dissociation, the enzyme was 
stopped with BRDM-medium supplemented with 10% FBS, to be then centrifuged at 1500 
rpm, 2 min. 
RPE single cells were then plated on pre-coated wells, either 6-well plates, 24-well plates 
with glass coverslips, or 24-well transwell plates. In each case, coating was performed by a 
30 min incubation with 0.01% Poly-L-Ornithine at room temperature, followed by a 4 h 
incubation with 20 μg/ml Laminin at 37°C and 5% CO2 with a PBS-washing step in between. 
For plating freshly dissociated RPE cells, 20 ng/ml EGF, 20 ng/ml FGF2, 2 μg/ml heparin, 10 
μM Y-27632 were added to BRDM medium. For the first day, the medium was additionally 
supplemented with 10% FBS to improve survival and adherence of cells.  
As soon as RPE cells reached confluence, all supplementation to BRDM was omitted. 
For splitting of RPE cells, the same supplementation steps were used. 
4.1.3. Generation of pJG-IRBP-eGFP lentiviral particles  
Lentiviral particles were generated using Lenti-X cells purchased from Takara. Cultivation 
medium was Lenti-X medium (DMEM with 10% FBS. Cells were grown in 10 cm-petri dishes 
(culture treated) to 80% density to be then transfected. The following transfection mix was 
prepared per 10 cm-dish of cells to be transfected. 
• 400 μl OptiMEM 
• 12 μg Target vector pJG-IRBP-eGFP 
• 5.5 μg psPAX2-Vector, lentiviral packing plasmid (gift from Didier Trono, Addgene 
plasmid # 12260) 
• 2 μg pMD2.G-Vector, envelope expressing plasmid (gift from Didier Trono, Addgene 
plasmid # 12259) 
• 70 μg Polyethylenimine  
The mix was incubated for 10 min at RT. 1 ml of DMEM was then added to the mix and 
dropwise pipetted onto the cells in the petri dish. 
Cells were then incubated for 4 h in the incubator at 37°C, 5% CO2 and 5% O2.  
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Medium in the petri dish was replaced with 8 ml Lenti-X medium. On day 2 and day 4 after 
transfection, medium was collected in 50 ml-tubes to be then used for lentivirus 
concentration. 
First, the medium in the tubes was centrifuged (1500 rpm, 2 min) to separate the cell pellet 
from virus supernatant. Next, the virus supernatant was sterile filtered using 0.45 μm filters. 
Lenti-X concentrator was added in a ratio of 1:3 (Lenti-X concentrator : virus supernatant). 
The solution was mixed and stored at 4°C overnight, then centrifuged again at 1500 g, 45 
min, at 4°C and supernatant was discarded. The final pellet of virus particles was then 
dissolved in DMEM/F12 (1 ml/ petri dish) and stored at -80°C. 
4.1.4. Transduction of RPE cells 
RPE cells in adherent cultures were transfected with pJG-IRBP-eGFP lentiviral particles by 
incubating them in BRDM with 10% FBS overnight, washing three times with PBS on the next 
day and cultivation with BRDM, as previously mentioned. Successful transduction was 
checked by monitoring green fluorescence under the microscope. 
4.1.5. Loading of RPE cells into the retina-on-a-chip 
First, individual chips were moved into 10 cm petri dishes and excess liquid was removed 
using a vacuum pump. Attention was paid that the wells and channels are still filled with 
liquid and no air bubbles can enter the system. Chips were then coated for 2 h at 37°C with 
50 μg/ml laminin diluted in DMEM/F12. Directly before loading cells, the coating solution 
was removed and wells were washed and then filled with BRDM supplemented with 20 
ng/ml EGF, 20 ng/ml FGF2, 2 μg/ml heparin, 10 μM Y-27632 and 10% FBS. 
RPE cells loaded into the chips system were confluent, pigmented and had been starved for 
at least 2 weeks, unless mentioned otherwise. 
Wells of RPE to be loaded were dissociated by first washing with PBS once and then adding 
warm AccuMax to the well (500 μl / 6 Well). Cells were incubated at least 10 min at 37°C and 
5% CO2, (depending on how long the RPE had been starved before, up to 40 min) until cells 
were detaching completely. To achieve a single-cell solution, cells were additionally 
resuspended in AccuMax 1-2 times before stopping the reaction with warm BRDM medium. 
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To avoid incomplete dissociation and cell clumps, the cell solution was additionally applied 
onto cell strainers, first onto a 70 μm, then onto a 40 μm cell strainer. Cells were then 
collected in a 15 ml tube and additional BRDM medium with 10% FBS was added before 
centrifugation at 1500 rpm, 2 min. The cell pellet was then resuspended in 1 ml BRDM 
medium with all supplements mentioned above and cells were counted in a Neubauer 
counting chamber. For each chip loaded, 108 000 cells were calculated and diluted in the 
appropriate volume of BRDM plus supplements (see above) including FBS for overnight 
attachment of the cells. 27 000 cells were then loaded in 4.5 μl per well by pipetting slowly, 
allowing the cells to sink to the bottom of the well. After loading, density per well was again 
checked at the microscope and corrected if necessary. Cells were then allowed to attach in 
the small volume of the well for 2 h in the incubator. Afterwards, 500 μl of medium were 
added on top of the chip for complete attachment overnight. The day after loading of RPE 
(unless mentioned otherwise), RPE chips were either connected directly to a syringe pump 
for cultivation or retinal organoids were loaded first before chips were connected to a pump. 
4.1.6. Loading of retinal organoids into the retina-on-a-chip 
Before loading ROs into the chips, medium was removed from the wells almost completely. 
8 μl of HyStem-C, a hyaluronic acid-based hydrogel that had been prepared before according 
to the manufacturer’s protocol, was then added to each well by pipetting. ROs which had 
been manually chosen before regarding their retinal morphology and size, were placed into 
the well by pipetting them into the liquid hydrogel on top of the membrane covered with 
RPE cells. One RO was placed per well. ROs were then gently moved into the center of the 
well and positioned with minimal distance to the RPE. Chips were incubated for 30 min at 
37°C without any medium added, to allow the hydrogel to become solid. Afterwards, chips 
inside the incubator were connected to a Legato 201 syringe pump for automatic medium 
supply with BRDM, supplemented with 100 μM taurine and 10% FBS at a constant rate of 20 
μl/h for 3-7 days. To further improve media flow and prevent evaporation, wells of the chips 
were covered using sterile adhesive tape (optical adhesive covers). 
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4.2. Chip production 
4.2.1. PDMS chip production 
Details of chip production are further described in (Achberger et al., 2019b). 
The retina-on-a-chip (RoC) was fabricated from polydimethylsiloxane (PDMS) in 2 layers 
(media layer + tissue layer), carrying a polyethylene terephthalate (PET) membrane in 
between.  
As a first step, 2 wafers (master molds) had to be produced. To generate the wafer for the 
media layer, SU8-50 photoresist was spin-coated onto a 4’’ silicon wafer that had been 
cleaned before. A height of 100 μm was achieved. The substrate was exposed to UV light 
and allowed to develop for 6 min in SU8 developer. 
The second wafer, required for RO culture (tissue layer), involves structures for an additional 
channel that will be referred to as tissue channel. The second wafer was generated in a 2-
step process: The base layer, intended for the membrane insert, with a height of 25 μm was 
generated by spin-coating SU8-3025 photoresist, subsequent exposure to UV light, and 
development for 4 min. A cleaning step was inserted before the next layer was fabricated on 
top of the first (as molds for the tissue channels). Therefore, SU8-3025 was spin-coated with 
a height of 40 μm and exposed to UV light and final development for 4 min. 
Both wafers were then silanized using chlorotrimethylsilane, to be used in a next step as 
negative master molds for Sylgard 184 PDMS (ratio 10:1, prepolymer:curing agent) that was 
poured onto the wafers. 
Generation of the lower layer (media layer) was achieved using exclusion molding and 
overnight curing at 60°C. Generation of the tissue layer including the wells and tissue 
channels, was achieved with 25 g PDMS that was poured onto the master mold and 
overnight curing at 60°C. 
After carefully removing both PDMS layers from their master molds, holes were punched 
into the tissue layer with a 2 mm biopsy puncher to generate 4 wells for later cultivation of 
cells and RO. Further, holes were punched with a 0.75 mm biopsy puncher to generate an 
inlet and an outlet for the medium. 
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PDMS layers and glass slide (170 μm) were cleaned. Next, the media layer bottom side and 
the surface of the glass slide were treated with oxygen plasma (50 W for 30 s) to be then 
bonded. Next, the PDMS-tissue layer needed to be bonded to a membrane: 
Porous PET membranes with a diameter of 20 mm (pore size: 3 μm, thickness 10-20 μm) 
were used for this purpose that had been treated previously with bis-[3-
trimethoxysilypropyl]amine for functionalization, to be then treated with oxygen plasma. 
Positioning of the membrane on the plasma-treated tissue layer was performed under the 
microscope. 
To achieve plasma bonding between both PDMS layers, the surfaces of both layers were 
again treated with oxygen plasma (50 W, 30 s) and the setup was carefully aligned under the 
microscope. Stabilization was achieved by baking at 60°C overnight. For transportation and 
storage, the chips were plasma-activated (50 W, 5min) and then placed in sterile PBS to 
prevent air from entering the system. 
4.2.2. Production of an agarose chip version 
For cryo-sections, we build a specialized version of the RoC, made of 4% agarose in BRDM + 
10% FBS. As the standard version of the RoC, this version contains four wells for cultivation 
of the ROs, as well as a semipermeable PET membrane, for cultivation of the RPE cells. The 
loading of RPE and ROs was performed as described before. Agarose RoCs were fixed using 
4% PFA and 10 % sucrose in PBS for 2 h at RT. Cryoprotection was achieved using a sucrose 
gradient (10% sucrose for 10 min, then 20% sucrose for 1h) and storage overnight in 30% 
sucrose at 4°C. For cryoembedding, tissue-tek O.C.T. cryomatrix was used to cover the 
agarose RoC, before freezing it in liquid nitrogen. Cryosections of 14 μm thickness were cut 
using a cryostat and collected on superfrost glass slides, to then be stored at -20°C for 
immunohistochemistry. 
4.3. Readouts 
4.3.1. Purification of total RNA 
Isolation of total RNA was performed using the Qiagen RNeasy Plus Mini Kit or the RNeasy 
Plus Micro Kit, depending on the expected RNA amount. Purification steps were performed 
according to the manufacturer’s protocol. For adherent cells, for organoids in suspension 
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culture, as well as for chip-cultured cells or organoids, the same protocol was applied. 
Briefly, cells or organoids were washed twice with PBS before lysis buffer (RLT buffer) was 
applied. Resuspension was performed inside the lysis buffer. In the case of adherent cells in 
standard dish culture, cell scrapers were used in addition to help to detach all cells. 
QiaShredder columns were used for homogenization and centrifugation was performed at 
13 300 rpm, 2 min. To eliminate genomic DNA, gDNA eliminator spin columns were used to 
centrifuge the homogenized lysate at 10,000 rpm for 30s. For precipitation of RNA, 70% 
ethanol were applied to the flow-through, mixed and transferred to RNeasy spin columns for 
centrifugation at 10,000 rpm for 15 s. Three washing steps followed with RW1 and RPE 
buffer (10,000 rpm for 15 s, 15 s, 2 min). Finally, total RNA was eluted using 30 μl of RNase-
free water, directly applied to the spin column membrane and centrifugation at 10,000 rpm, 
1 min. Flow-through was kept on ice for measurement of the RNA concentration and then 
stored at -80°C. 
4.3.2. Gene expression analysis 
Gene expression analysis was performed on the Biomark Fluidigm for an automated qRT-PCR 
reaction with Taqman assays as probes for quantification of the genes of interest. 
80 ng of purified RNA was used as template for cDNA synthesis with the following material: 
• 1 μl 5x RT Buffer  
• 0.25 μl dNTPs 
• 0.313 μl Hexanucleotide Mix  
• 0.25 μl MMLV RT  
• 0.438 μl H2O 
The mixture was incubated for 1 h at 37°C, followed by 10 min at 85°C. 
Taqman assay plates (96 well) were loaded according to the manufacturer’s protocol, to be 
then placed in the Fluidigm machine. 
4.3.3. Quantification of fluorescence intensity after PI treatment 
The intensity of the PI signal was quantified with the help of the open source software 
ImageJ (https://imagej.nih.gov/) for ROI selection and calculation of mean intensity pixel 
values of this area. 
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To avoid confounding effects of background fluorescence, an image of the fluorescent signal 
was taken before and after PI treatment. For calculation of the real PI signal, ROI were 
selected and were calculated. Intensities before PI-treatment were then subtracted from 
intensities after PI-treatment. 
Since the images were taken from underneath the RPE, RO signals should be regarded as a 
combination of RO signals with signals from the RPE directly underneath. Therefore, the 
calculation of the RO signal required to subtract the RPE signal. The RPE signal had to be 
calculated from the surrounding area (RoC minus RO). 
 
The following calculation was performed: 
I[RPE] =(I[RoC]*A[RoC]- I[RO+RPE]*A [RO]) / (A [RoC]- A [RO]) 
I[RO] = I[RO+RPE]- I[RPE] 
 
A[X]: Area of [X] 
I[X]: Mean Intensity of X 
 
[RO]: only RO without RPE underneath  
[RoC]: the complete Retina-on-a-Chip (RO + underlying RPE + surrounding RPE) 
[RPE]: RPE in the RoC (not underneath the RO) 
4.3.4. ELISA VEGF-A assay 
To able to measure apical vs. basal secretion, we produced specialized chip versions made of 
PDMS with an additional apical media channel to connect the 4 chip compartments. These 
double channel RoC allowed the collection of the apical media (from above the RPE layer) 
and the measurement of VEGF-A secretions. Further, it allowed the comparison to the basal 
secretion from the media flow below the RPE. 
RPE loading was performed as described before and cultivated with media flow generated 
from a syringe pump. After 14 days, media from the apical and basal channel were collected 
over 24h and frozen at -20°C. 
For measurement of the VEGF-A amount, a VEGF-A Human ELISA Kit was used. The ELISA 
assay was performed according to the manufacturer’s protocol. The media were collected 
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from (apical and basal) channels from 3 different RoCs. For calculation of the total VEGF-A 
amount per side, the starting volumina were measured.  
4.3.5. Transmission electron microscopy 
For transmission electron microscopy, either agarose RoCs or RoC without glass slide were 
used. The protocol is described in detail in (Achberger et al., 2019b). 
RoC were fixed within the chip using Karnovsky buffer (2.5% glutaraldehyde, 2% 
paraformaldehyde, 0.1 M sodium cacodylate buffer, pH 7.4) overnight at 4°C. Chips were 
then washed for 30 min with 0.1 M sodium cacodylate buffer and placed for 1.5 h in OsO4 
for postfixation. Samples were then washed three times in cacodylate buffer and 
dehydrated in 50% ethanol. For counterstaining, 6% uranyl acetate (in 70% ethanol) were 
used and final dehydration was achieved in graded ethanol solutions. 
Samples were then gradually infiltrated with Epon resin, starting with a 2:1 solution of 
aceton and Epon for 1 h, then with a 1:1 solution for 1 h and finally with pure Epon. 
Polymerization of the resin was achieved by overnight incubation at 60°C. 
After polymerization, the RPE-RO co-culture on the PET membrane could then be removed 
from the chip setup using biopsy punchers. The removed samples in Epon were embedded 
in fresh Epon in molds for subsequent sectioning and were then incubated for 12 h at 60°C 
and 2 h at 90°C. 
Ultrathin sectioning into 50 nm sections was performed using a Reichert Ultracut S and 
samples were collected on copper grids. Reynolds lead citrate was used for counterstaining. 
Finally, a Zeiss EM 900 transmission electron microscope was used for sample analysis. 
4.3.6. Immunohistochemistry  
Staining of cells on coverslips and transwells: 
RPE cells on coverslips or on transwell inserts were fixed in the culture plate with 4% PFA 
and 10% sucrose in PBS for 20 min at RT. In case of transwell insert, the membrane was cut 
out and transferred into a 24 well plate. Blocking and permeabilization was performed in a 
combined step using 5% normal donkey serum (NDS) and 0.2% triton-X in PBS for 1 h at RT. 
Primary antibodies were diluted in blocking solution and applied to the coverslips or 
membranes in the plate for overnight incubation at 4°C. A washing step was performed with 
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PBS, three times for 5 min at RT. Secondary antibodies were diluted in blocking solution and 
incubation was performed for 2 h at RT. A washing step was performed with PBS, three 
times for 5 min at RT. For mounting, ProLong Gold antifade with DAPI was used.  
In case of LAMP2 stainings, permeabilization was performed with 0.5% saponin instead of 
triton-x. In this case, all washing steps and antibody dilutions included 0.1% saponin in PBS. 
 
Staining of cryo-sections: 
For cryo-sections, the specialized agarose-version of the RoC was used and 14 μm thick cryo-
sections were cut as described above. After thawing of frozen slides, the tissue was 
rehydrated using PBS for 15 min at RT. Blocking and permeabilization was performed in a 
combined step using 5% NDS and 0.2% triton-X in PBS for 1 h at RT. 
Primary antibodies were diluted in blocking solution and applied to the cryo-sections for 
overnight incubation at 4°C. A washing step was performed with PBS, three times for 3 min 
at RT. Secondary antibodies were diluted in 1:1 blocking solution : PBS and incubation was 
performed for 2 h at RT. A washing step was performed with PBS, three times for 3 min at 
RT. For mounting, ProLong Gold antifade with DAPI was used. 
 
In situ chip staining: 
Immunohistochemistry of the whole RoC was performed using a syringe pump as follows: 
RoCs were fixed in 4% PFA in PBS for 20 min at RT. Blocking and permeabilization was 
performed in a combined step using 5% normal donkey serum (NDS) and 0.2% triton-X in 
PBS for 1 h at RT. This step was repeated for an additional 1 h with fresh solution. Primary 
antibodies were diluted in blocking solution for 1-2 days at 4°C. A washing step was 
performed with PBS, three times for 2 h at RT. Secondary antibodies were diluted in blocking 
solution and incubation was performed overnight at 4°C. A washing step was performed 
with PBS, three times for 2h at RT. For counterstaining of the nuclei, HOECHST 33342 was 
applied for 10 min at RT. An additional washing step was performed with PBS, three times 
for 2 h at RT. 
In case of LAMP2 stainings, permeabilization was performed with 0.5% saponin instead of 
triton-x. In this case, all washing steps and antibody dilutions included 0.1% saponin in PBS. 
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4.3.7. Phagocytosis assay 
Phagocytosis of bovine photoreceptor outer segments (POS): 
HiPSC-derived RPE was plated on coated coverslips in 24 well plates. After 1 day, RPE was 
incubated with POS in BRDM for 2 h at 37°C (at a density of 10 POS per RPE). RPE cells were 
washed three times with PBS to remove residual POS and plates were moved back to the 
incubator for additional 2 h. Then, cells were fixed with 4% PFA and 10% sucrose in PBS for 
20 min at RT. 
4.3.8. Drug treatment  
Drug treatment in the RPE dish: 
HiPSC-derived RPE p2 cells that had been grown in standard dish culture on coated cover 
slips in 24 well plates for 1 day were treated with different concentrations of chloroquine (0, 
20, 40, 80 μg/ml in BRDM) over 24 h. Afterwards, vacuolization was monitored under the 
phase-contrast microscope and, following fixation with 4% PFA, immunohistochemistry was 
used to stain for the lysosomal membrane protein lysosome-associated marker protein 2 
(LAMP2) and cleaved caspase 3 (CASP3). 
 
Drug treatment in the RoC: 
RPE and ROs were co-cultivated in the RoC for 3 days. Then, the co-culture RoCs were either 
treated for 3 additional days with chloroquine (at 20 μg/ml or 80 μg/ml diluted in BRDM) or 
treated for 6 additional days with gentamicin (at 0.5 mg/ml and 2.5 mg/ml in BRDM). For 
both treatments, control RoCs only supplied with BRDM and the solvent we used. 
RoCs were then analyzed using live cell imaging directly after treatment with 3 μM 
propidium iodide (PI) and HOECHST. In case of chloroquine treatment, RoCs were then fixed 
with 4% PFA, and immunohistochemistry was performed with the marker LAMP2 for 
lysosomal imaging. 
4.4. Statistical analysis 
Statistical analyses were performed using Graphpad Prism software version 8.2.0. Statistical 
tests used were students t-test (Figure 6d, Figure 7f, Figure 9d), one-way ANOVA with 
Bonferroni post-hoc test (Figure 14e), one-way ANOVA with Dunnet post-hoc test (Figure 
18b, Figure 19b) and two-way ANOVA with Bonferroni post-hoc test (Figure 19c). 
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Results are provided as mean values ± standard error of the mean (S.E.M.). Statistical 
significance was represented as follows: p < 0.05 = * ; p < 0.01 = ** ; p < 0.001 = ***. 
  
- 51 - 
 
 
5. Results 
5.1. Retinal organoid and RPE differentiation protocol 
The first step for establishing a retinal model system, was to generate retinal tissue in the 
form of retinal organoids (ROs). 
The starting material for this differentiation were human induced pluripotent stem cells 
(hiPSCs) derived from healthy donors by lentiviral reprogramming of keratinocytes. 
Retinal differentiation was performed according to the protocol by Zhong et al. (Zhong et al., 
2014) with several adaptations. An overview of the differentiation with the corresponding 
characteristic steps as observed under the bright-field microscope is provided in Figure 5. 
In an initial step, embryoid bodies (EBs, Figure 5b) were generated from hiPSCs (Figure 5a). 
This step was used to initiate the differentiation and was defined as day 0 of differentiation. 
After 7 days of culture in suspension, EBs were plated on coated dishes and cultured 
adherent (Figure 5c). Neural rosettes started to form during this process. By day 24, neural 
retina areas could be identified morphologically by a bright appearance (Figure 5d, red 
circles) and were manually detached using a pipette tip. The detached retinal areas were 
then again cultured in suspension and started to form spherical structures within 1-2 days, 
referred to as retinal organoids (ROs), (Figure 5e). ROs can be identified by a bright 
appearance and a striped outer rim, indicating development of retinal cells. Moreover, 
pigmented dark parts could be identified, which are RPE cells and were detached from the 
neural retinal part of the organoid using fine scissors (Figure 5e). 
The removed RPE cell clump was dissociated into single cells and cultured as an adherent 
mono-cell-layer (Figure 5g) while the remaining ROs (Figure 5f) can be kept in suspension 
culture for an extended amount of time. 
After differentiation, RO-characterization out-of-chip was performed. Results are provided in 
detail in Achberger, Probst and Haderspeck et al., 2019. 
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Figure 5: Steps of retinal organoid differentiation.  
Number of days of differentiation is indicated on the left. Characteristic steps are shown under the bright-
field microscope, including a) hiPSC colony, b) embryoid body (EB) formation, c) plating of EBs and 
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formation of neural rosettes, d) retinal field formation and area to be detached in red, e) retinal organoid 
in suspension culture with pigmented RPE are to be dissected along the line shown in red, f) retinal 
organoid in suspension culture, g) RPE cells  as adherent culture. 
5.2. Establishment and characterization of individual culture 
chips  
5.2.1. The retinal organoid chip 
To analyze whether the cells keep their morphology and characteristics also inside the chip 
environment, the ROs and RPE tissue were first examined separately in individual 
monoculture chips made of polydimethylsiloxane (PDMS). The concept of the individual-
culture chips is shown in Figure 6a and Figure 7a. The culture chip for ROs consisted of 4 
individual chambers (Figure 6a), each for the culture of one RO. Media supply was achieved 
by pipetting medium on top of each organoid onto the chamber (Figure 6b). 
First, ROs were loaded into the specialized chips inside a hyaluronic acid-based hydrogel and 
morphology was monitored over a period of 3 days. As depicted in Figure 6c, the 
morphology did not change during that time and the ROs did not show any signs of cell 
degeneration since appearance of organoids under the bright-field microscope was constant 
over the examined period of 3 days. After this cultivation period, the organoids were 
retrieved from the chip, total RNA was isolated and mRNA expression levels analyzed and 
compared relative to dish-cultured ROs (Figure 6d). Typical retinal cell markers for retinal 
progenitor cells (RAX, LHX2, VSX2), Müller glia (GLUL, ANXA4), bipolar cells (PRKCA), 
horizontal cells (PROX1), photoreceptor cells (CRX, NRL GT1), photoreceptor outer segments 
(PRPH2), as wells as for the outer limiting membrane (ZO1) were analyzed in this context. 
The mRNA expression levels in none of the measured characteristic retinal cell types or 
structures changed significantly compared to dish cultured organoids, except for the outer 
limiting membrane-marker ZO1, where expression was increased significantly under chip-
culture (Figure 6d). 
Next, retinal organoids were analyzed for key structures and morphology on electron 
microscopic-level (Figure 6e). Fine microscopic structures characteristic for photoreceptors 
of retinal organoids at that stage were compared between standard dish-cultured organoids 
and chip-cultured organoids. For both conditions, the same characteristic structures could 
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be identified, such as segment-like structures, indications of membrane disc formation, and 
the typical ribbon synapse structures (Figure 6e). 
Consequently, we can conclude that ROs maintain their morphology and typical 
marker expression inside the chip environment. 
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Figure 6: Retinal organoid-individual culture-chip. 
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a) Scheme of RO-chip as seen from the side. The chip is made of PDMS and consists of 4 chambers that 
form wells for the culture of one RO per chamber. b) Scheme of RO-chip culture. ROs were embedded 
inside hyaluronic acid-based hydrogel into the chambers. ROs were supplied with medium from on top of 
the chamber. c) ROs were cultured in the chip for 3 days and observed under the bright-field microscope 
for morphologic changes. d) After culture in the chip for 3 days, ROs were retrieved from the chip and 
mRNA expression levels of characteristic markers for retinal progenitor cells (RAX, LHX2, VSX2), Müller glia 
(GLUL, ANXA4), bipolar cells (PRKCA), horizontal cells (PROX1), photoreceptor cells (CRX, NRL, GT1), outer 
segments (PRPH2) and outer limiting membrane (ZO1) were analyzed. Expression levels were compared to 
standard-dish cultured ROs. Statistical analysis was performed of RO chip vs. RO dish. e) Electron 
microscopic images of chip-cultured and dish-cultured ROs, showing characteristic structures of 
photoreceptor cells, including segment outgrowth, outer segment membrane discs and ribbon synapses. 
ANXA4=Annexin A4; BC=bipolar cells; CRX= Cone-Rod Homeobox; GLUL= Glutamine Synthetase; GNAT1=G 
protein subunit alpha transducin 1; HC=horizontal cells; OS=outer segments; LHX2= LIM Homeobox 2; 
NRL= Neural Retina Leucine Zipper; OLM=outer limiting membrane; OS=outer segments; 
PRC=photoreceptor cells; PRKCA= Protein Kinase C Alpha; PROX1= Prospero Homeobox 1; 
PRPH2=Peripherin 2; RAX= Retinal Homeobox Protein Rx; RO=retinal organoid; VSX2= Visual System 
Homeobox 2; ZO1=Zonula Occludens 1. Error bars: S.E.M. *p-value<0.05 (Two-sided student’s t-test). 
Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
5.2.2. The RPE chip 
To monitor cell morphology and characteristics of the RPE cells inside the chip environment, 
another monoculture chip was established, only containing a confluent layer of RPE cells. 
The RPE chip, also made of PDMS, consisted of 4 individual chambers with a polyethylene 
terephthalate (PET) membrane at the bottom and a medium-channel underneath (Figure 
7a). The concept of a single chip chamber is represented in Figure 7b. RPE cells were grown 
adherent to the PET membrane. 
RPE cells that were used for culture in the chip were cultured initially in standard dish-
culture and were starved (cultured without addition of FBS) for at least 2 weeks (Figure 7c). 
While cells lost their pigmentation during proliferation steps, dark pigmented areas were 
again starting to form if RPE cells were starved over several months (Figure 7d). 
Consequently, RPE cells can regain these characteristics, which could also be identified 
under the electron microscope (Figure 7f). The RPE cells were dissociated before they were 
loaded in a defined cell number into the chip chambers and given 24 h for attachment.  
The cells were monitored over a period of 7 days. After 7 days, the morphology of the cells 
was cobblestone-like and cell borders were again visible (Figure 7e). The cells were then 
retrieved again from the chip, total RNA was isolated and mRNA expression levels of 
characteristic RPE markers were analyzed (Figure 7f). The chip-cultured RPE (RPE chip) was 
compared to dish-cultured RPE after 14 days of starvation in dish-culture (RPE dish starved). 
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Further, we also analyzed RPE cells directly after dissociation (passage 0, RPE dish p0) to 
monitor the effect of starvation (Figure 7f). All RPE-markers analyzed (RPE65, BEST1, ZO1, 
MITF, GP100, PEDF) were significantly higher expressed in starved RPE cells compared to p0 
RPE cells. Moreover, chip-culture of 7 days led to comparable expression levels of all RPE 
markers as in 14 day-starved dish-cultured RPE, except for the tight junction-marker ZO1, 
where chip-cultured RPE cells showed significantly higher expression levels (Figure 7f). We 
can conclude that the starvation episode is important for RPE cells with regard to the 
expression of characteristic markers and further, that RPE cell keep their characteristics in 
the chip environment and that this culture can even help to improve tight junction 
formation.   
- 58 - 
 
 
 
Figure 7: RPE-individual culture-chip. 
a) Scheme of RPE-chip as seen from the side. The chip is made of PDMS and consists of 4 chambers that 
form wells for the culture of a monolayer of RPE cells. b) Scheme of RPE-chip culture. RPE cells were 
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cultured adherent to the PET membrane. Medium was supplied from on top and via a medium channel 
underneath that can be connected to a syringe pump. c) Image of RPE cells after 2 weeks of starvation in 
dish-culture. d) Image of RPE cells after several months of starvation in dish-culture. Dark pigmented areas 
started to form. e) RPE after 7 days of chip culture. f) mRNA expression levels of RPE cells directly after 
dissection from the RO, dissociation into single cells and subsequent dish-culture (RPE dish p0), RPE cells at 
passage 3 after 2 weeks of starvation in dish-culture (RPE dish starved) and RPE cultured in the RPE chip 
for 7 days (RPE chip). mRNA expression levels are shown relative to RPE p0. Characteristic RPE markers 
were analyzed including RPE65, BEST1, ZO1, MITF, GP100 and PEDF. Statistical analysis was performed of 
starved vs. p0 RPE cells and of chip vs. starved RPE cells. BEST1= Bestrophin 1; GP100= Melanocytes 
Lineage-Specific Antigen GP100; MITF= Microphthalmia-Associated Transcription Factor; PEDF=Pigment 
Epithelium-Derived Factor; RPE65=Retinoid Isomerohydrolase RPE65; ZO1=Zonula Occludens 1. Scale bars: 
c) 100 μm, d) 100 μm, e) 100 μm, g) 1 μm, Error bars: S.E.M. *p-value<0.05, **p-value<0.01, ***p-
value<0.001 (Two-sided student’s t-test). Figure adapted from Achberger, Probst and Haderspeck et al., 
2019 (CC BY 4.0).  
5.2.2.1. Immunohistochemistry of the RPE chip 
As a next step, we aimed to verify characteristic marker expression inside the RPE chip on 
protein level using immunohistochemistry (Figure 8). Expression of RPE cell markers, 
including MITF and ZO1 was first compared between 7-day dish-cultured (Figure 8a) and 7-
day chip-cultured (Figure 8b) RPE cells. 
The transcription factor MITF which is expressed in the nucleus and is an early RPE marker 
during differentiation, was found to be equally expressed in the nucleus of almost every cell 
after 7 days in chip-culture (Figure 8b left). This was comparable to the situation after 7 days 
in the dish (Figure 8a left). The tight junction marker ZO1, which usually can be found in 
more mature RPE cells, was not equally expressed in the chip environment (Figure 8b right) 
but rather found in clusters. This was however, still comparable to dish-cultured RPE at 7 
days, even though in the dish, the cell shape was more regular than in the chip at that time 
point. We concluded that longer cultivation of RPE cells in the chip might be necessary. 
Therefore, we decided to extent the cultivation period before monitoring marker expression 
again after 14 days in chip-culture and also before analyzing other markers characteristic for 
mature RPE cells (Figure 8c,d). On day 14, the tight junction marker ZO1 was found to be 
expressed in every cell and colocalization with the cytoskeletal marker phalloidin could be 
observed (Figure 8c left).  
The melanosomal marker Melanoma GP100 (also called Glycoprotein 100, GP100 or 
Melanocyte protein PMEL) was found in the majority of cells with positive vesicles filling the 
cell bodies (Figure 8c right). This additional indication of pigmentation also verified the 
results gained from mRNA expression levels in the previous section (Figure 7f). 
- 60 - 
 
 
Further, the transcription factors PAX6 and MITF which are both necessary during RPE 
differentiation were also analyzed again after 14 days in chip-culture (Figure 8d). For both 
markers, a positive staining in the nucleus of the cells could be observed. However, intensity 
of expression was found to be variable between cells. 
Consequently, observations made on mRNA level could be verified on protein level. We 
found the RPE markers MITF, PAX6, ZO1 and Melanoma GP100 to be expressed in RPE 
cultured in the chip environment. 
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Figure 8: Immunohistochemistry characterization of RPE chips and comparison to dish-cultured 
RPE. 
 a-b) Comparison of characteristic RPE-marker expression between (a) 7-day dish-cultured and (b) 7-day 
chip-cultured RPE cells stained for the nuclear RPE marker MITF (green, left) and for the tight junction-
marker zonula occludens 1 (ZO1, green, right). c) Immunohistochemistry of the 14-day chip-cultured RPE 
cells stained for the tight junction-marker zonula occludens 1 (ZO1, green, left) or for the melanosomal-
marker melanoma GP100 (MELANOMA, green, right) as well as for the cytoskeleton marker phalloidin 
(PHAL, magenta). d) Immunohistochemistry of the 14-day chip-cultured RPE cells stained for the nuclear 
RPE markers MITF (green, left) and PAX6 (green, right). Scale bars: 100 μm. Figure adapted from 
Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
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5.2.2.2. Polarization of RPE cells inside the RPE chip 
RPE cells in vivo are polarized cells since they grow as an adherent monolayer. 
Morphologically, polarization is verified by the apical formation of microvilli and a basal 
lamina on the basal side.   
To analyze whether the RPE cells in the chip show signs of polarization, we used 
immunohistochemistry to stain for ezrin, which is a marker protein for microvilli formation. 
Already on day 3 in chip-culture, this marker was found to be expressed in RPE cells inside 
the chip. The z-stack of an optical section in Figure 9a shows that the ezrin signal is polarized 
to one side of the cell, as it can also be seen in the 3D reconstruction in Figure 9b. The top 
view of the cell layer (Figure 9b, left) compared to the bottom view (Figure 9b, right) shows 
that ezrin is only expressed at the apical side of the cells and that expression is regular 
throughout the cell layer.  
The formation of microvilli was also analyzed using electron microscopy of RPE cells after 7 
days of chip-culture. In Figure 9c on the left, an RPE cell can be found with the upper side 
facing away from the membrane, consequently being the apical side. On the right, close-ups 
of the apical and the basal side of the cell are shown. We observed that the apical side of the 
RPE cell is carrying microvilli, whereas no microvilli can be found at the basal side. Here, 
signs of basal lamina formation can be found instead (Figure 9c). 
Polarization of RPE cells also manifests as polarized secretion of certain growth factors. One 
example is the vasculature endothelial growth factor (VEGF-A) which is predominantly 
secreted to the basolateral side of the RPE cell, since this is also the side of the cells facing 
the choroid layer in vivo. This factor plays an important role in the maintenance of 
choriocapillaries. Using ELISA assays, we measured the amount of VEGF-A secreted to the 
basal and to the apical side over 24 h in RPE cells cultured in transwells or chips for 14 days 
(Figure 9d). Whereas in transwell-cultured RPE cells, significantly higher concentrations of 
VEGF-A at the basal side could be measured (Figure 9d left), we found a strong tendency 
towards a higher basal secretion in chip-cultures, which was however, not significant (Figure 
9d right). 
Taken together, these results indicate that the RPE cells inside the chip environment show 
polarization on a morphological and functional level. 
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Figure 9: Characterization of polarization of RPE cells inside the RPE chip.  
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a) Immunohistochemistry of day 3 RPE chips, stained for the microvilli marker ezrin (red). X-y-projection of 
an 0.55 μm-thick optical section. b) 3D reconstruction in a side-angle of (a), from above (left) and below 
(right) the RPE cell layer. c) Electron microscopy of RPE cells cultured in the chip for 7 days. On the right, 
close ups of the left image are showing the apical side of the RPE cells forming microvilli and the basal side 
of the RPE cells forming a basal lamina. d) ELISA assay of secreted VEGF-A amount measured over 24h 
from the apical and basal side of RPE cultured over 14 days in transwells (apical n=3, basal n=3) and RPE 
cultured over 14 days in the RPE chips (apical n=4, basal n=3). Blue: DAPI. Scale bars: a) 100 μm, c) left 5 
μm, c) right 1 μm. Error bars: S.E.M. p= value, *p-value<0.05 (Two-sided student’s t-test). Figure adapted 
from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.3. The retina-on-a-chip as a co-culture device for retinal 
organoids and RPE 
5.3.1. Description of chip-setup 
After individual culture chips had been analyzed, we combined both tissues in a retina-on-a-
chip (RoC). The aim was to bring the ROs into close and physiological contact to the RPE, to 
replicate the situation of the retina in vivo as it is shown schematically in Figure 10a. 
Figure 10b and c show the setup of the RoC. The chips features 4 individual chambers (Figure 
10b). Each chamber forms a well for the cultivation of one RO and a layer of RPE cells 
underneath. A side-view schematic representation of the chambers including ROs and RPE is 
provided in Figure 10c and a corresponding bright-field image is provided in Figure 10d. 
The chip is made of 2 layers of a biocompatible and optically clear plastic called PDMS, as 
used before for the individual-culture chips. The upper thick layer of PDMS forms the well 
for cell cultivations, whereas the lower layer forms a channel for media supply. Both PDMS 
layers are separated by a semipermeable and porous membrane made of PET with a pore 
size of 3 μm. This membrane allows attachment of the RPE cells while at the same time 
protecting the cells from shear forces generated by the media flow underneath. The chip 
further features an inlet and an outlet channel (Figure 10b) for medium supply. The chip can 
then be positioned onto a thin glass slide to be placed into a petri dish during cultivation 
which also allows microscopic analysis at a later point. Medium is solely supplied via a 
syringe pump (except for the day after RPE loading). For loading of cells, the wells are 
accessible from above, while during cultivation, the wells are sealed on top. 
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Figure 10: Setup of the retina-on-a-chip. 
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a) Schematic representation of the retinal layers inside the human eye, showing the close contact of 
photoreceptor outer segments and RPE cells. b) left: image of the RoC, which is hold in a person’s hand for 
a better impression of the dimensions. The bottom (medium) channel is filled with a red fluid, the optional 
upper (culture) channel is filled with blue fluid. b) right: schematic representation of the RoC including one 
RO and RPE cells. c) 3D-schematic representation of the RoC (© Fraunhofer IGB). d) Side view image of one 
loaded well of the retina-on-a-chip to provide a better impression of the dimensions. At the bottom of the 
well, the RPE layer is visible as cells with pigmentation. On top, the retinal organoid can be found. Scale 
bar = 1000 μm. Figure adapted from Achberger, Probst and Haderspeck et al., 2019. 
 
5.3.2. Loading of RPE and RO into the retina-on-a-chip  
In the following, the several steps of the loading process of the RoC are described and 
depicted in Figure 11. The first step was the loading of RPE cells into the RoC. RPE cells were 
dissociated into single cells and could then be loaded in a defined cell number from the top 
of the chamber onto the coated PET membrane. This step is shown schematically in Figure 
11a and d, as well as under the bright-field microscope in Figure 11g. RPE cells were then 
allowed to attach to the membrane overnight to form a confluent monolayer. During that 
time, medium was supplied from above, by pipetting a single media drop onto the chip. 
After 1 day, RPE cells usually form a dense monolayer of cells, if seeded at the correct cell 
density. This step is shown schematically in Figure 11b and e, as well as under the bright-
field microscope in Figure 11h. The RPE cells were then supplied with medium via the 
medium channel underneath the PET membrane using a syringe pump connected to the 
chip. The chambers were sealed from on top, to prevent evaporation or contamination.  
Between 1-3 days after RPE seeding, ROs were then loaded into the chip. For this step, the 
sealing of the chamber was removed again to make them accessible from the top. One RO 
was transferred into each well and the well was filled with hyaluronic acid-based hydrogel. 
This hydrogel allowed nutrition of the organoid through small pores, while at the same time 
keeping the RO in place and preventing the RO-cells from direct attachment onto the RPE 
cells which would result in outgrowth of cells. Via this loading protocol, a defined space 
between RO and RPE should be achieved. This step is shown schematically in Figure 11c and 
f, as well as under the bright-field microscope in Figure 11i. Chips were then again connected 
to the syringe pump and chambers were sealed from the top.  
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Figure 11: Scheme and images showing steps of loading procedure of the retina-on-a-chip. 
a-c) Scheme of top view of chip: during RPE loading (a), 1 day after RPE loading (b), and during RO loading 
(c). d-f) Scheme of side view of chip: during RPE loading (d), 1 day after RPE loading (e), and during RO 
loading (f). g-i) Bright-field images: taken during RPE loading (g), 1 day after RPE loading (h), and during 
RO loading (i). a,d,g) On day 0, RPE cells were loaded as single cells after coating of the membrane. RPE 
cells can either be loaded via channels or from on top of the well in a defined cell number. After loading of 
RPE cells, medium was supplied via pipetting from on top of the well. Medium is shown in magenta. b,e,h) 
1 day after loading, RPE cells grew adherent to the membrane and formed a dense monolayer. Cell 
borders became visible. Medium was now supplied via the medium channel below the RPE. c,f,i) After 1-3 
days, ROs were loaded into each chamber, inside a hyaluronic acid-based hydrogel (blue). Medium was 
again supplied via the medium channel (see arrow). Scale bars are g) 500 μm, h) 100 μm, i) 500 μm. Figure 
adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.3.3. Analysis of the distance between RPE and retinal organoid 
inside the chip 
After the behavior of individual tissues during cultivation had been evaluated, the co-culture 
RoC was examined. One important aspect to state whether a physiological setup inside the 
chip can be achieved, is the distance between RPE and RO. In a physiological setting, a close 
proximity of both tissues is necessary for the RPE to fulfill is functions of phagocytosis, 
nutrient-, as well as oxygen supply (Kurihara et al., 2016; Sparrow et al., 2010). 
To answer this question, both tissues were labeled for fluorescence-imaging before loading 
them into the chip. RPE cells were labeled using viral transduction with an IRBP-GFP 
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construct that marks all RPE cells in green (Figure 12a, left) while photoreceptor outer 
segments of the RO were labeled using PNA-lectin. This lectin protein binds to outer 
segments of photoreceptors (Blanks and Johnson, 1984). It was coupled with the Alexa-fluor 
chromophore 568 that would mark all segments in red (Figure 12a, right).  
After labeling, RPE as well as ROs were loaded into the chips as described before and live-cell 
imaging was used to visualize the position of both tissues (Figure 12b,c). In Figure 12b, a 3D-
rendering shows the position and approximate distance between marked RO-segments and 
RPE. However, to gain more precise information on the distance, we used x-y-projections 
from optical sections (exemplarily shown in Figure 12c) and measured the distance over 12 
images from different chip compartments. The calculated mean distance measured was 5 
μm (± 3.19 μm) (Figure 12e). Consequently, we concluded that a defined setup with a small 
distance could be achieved with the RoC, as monitored directly after culture setup. 
To analyze how culture over several days impacts the setup and respective positions of 
tissues in the chip, we used whole-mount immunohistochemistry of chips co-cultivated for 7 
days to mark whole rod photoreceptors with rhodopsin, as well as whole RPE cells and 
whole organoids with the cytoskeleton marker phalloidin (Figure 12d). In this case, live cell 
imaging was not possible since it only allowed tracking of marked cells over short periods. 
An x-y-projection of a chip compartment after immunohistochemistry is shown in Figure 
12d. This image provides the impression that photoreceptor segment tips and RPE cells were 
in close apposition, possibly even closer compared to directly after setup. Rhodopsin-
positive signals were found not only connected to the RO (identified by a phalloidin-signal) 
but also within the layer of RPE cells (identified by DAPI and phalloidin). 
The question whether on-chip-culture in the RoC actually leads to improved segment 
formation was analyzed in greater detail within the next section.  
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Figure 12:  Analysis of distance between RO and RPE in the RoC. 
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a) Photoreceptor segments from ROs were labeled with PNA-lectin Alexa Fluor 568 (red), RPE cells were 
labeled with an IRBP-GFP viral vector (green) construct before insertion into the chip. Live-cell imaging 
shows successful labeling. b-c) Live-cell imaging of co-culture chips after introduction of labeled ROs and 
RPE from a). b) 3D rendering of co-culture chip showing position of RO-segment tips vs. RPE cells. c) x-y-
projection from optical sectioning as exemplary image to measure distance (d, blue arrows). d) Whole-
mount in situ immunohistochemistry of day 181-RO and RPE co-cultured for 7 days in the RoC, stained for 
rhodopsin (green, rods) and phalloidin (red, cytoskeleton). Nuclei were stained with DAPI (blue). c-d) White 
dotted lines mark the surface of the RO (at the level of the OLM) and the surface of the RPE, respectively. 
e) Calculated mean distance between RO-segment tips and RPE over n=12 different chip compartments as 
shown in c). Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.4. Functional analysis of retinal organoids and RPE in the 
retina-on-a-chip  
5.4.1. Analysis of photoreceptor segment formation and 
maturation 
To be able to state whether the close proximity of both tissues, the ROs and the RPE, 
actually results in a functional interaction, we looked at some of the key functions as they 
would be observed in vivo. The first was to analyze if the presence of the RPE in the chip-
setup leads to improvement of photoreceptor-segment outgrowth from the organoid. 
Therefore, we used immunohistochemistry to stain for the typical segment marker proteins. 
However, to be able to use immunohistochemistry, we built a specialized chip-setup, made 
of agarose, that would allow cryosectioning of the organoid and RPE inside the chip without 
destroying or moving the tissue. 
We found that the space between ROs and RPE was filled with punctae positive for the rod 
marker rhodopsin and the outer segment marker ROM1 indicating that the photoreceptors 
facing the RPE possess these segments (Figure 13a). At higher magnification (Figure 13b), 
the positive punctae seem to form long processes of segment-like structures. 
Next, we aimed to quantify the number of outer segments from organoids cultured in our 
standard PDMS chips together with RPE (RoC w/ RPE), relative to organoids cultured in the 
chip without RPE (RoC w/o RPE) and also in comparison to standard dish-cultured organoids 
(dish RO). For this purpose, electron microscopic slides from organoids (cultured for 7 days 
under the respective condition) were analyzed and outer segment structures per slide were 
counted manually. Exemplary pictures of each condition can be found in Figure 14a-c. 
Segment-like structures were identified by organized membrane-stack formations that are 
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shown in Figure 14d. The number of segment structures per 100 μm was compared between 
each condition (Figure 14e). 
The mean number of outer segments was significantly higher in the organoids from co-
culture chips, compared to standard dish-cultured organoids (Figure 14e) and also in 
comparison to RoC cultured without RPE (Figure 14e). We concluded that the chip setup 
leads to improved segment outgrowth and that especially the co-cultivation with RPE cells in 
a physiological manner can improve the formation of photoreceptor segments. 
 
 
 
Figure 13:  Photoreceptor segment-formation. 
Immunohistochemistry of cryosections from a specialized agarose-chip-version cultured 7 days with d260 
ROs and RPE. Markers stained for included the outer-segment marker ROM1 (green), the cytoskeleton-
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marker phalloidin (PHAL, white) and rhodopsin as a marker for rod photoreceptors (RHOD, red). Nuclei 
were stained with DAPI (blue). B is an area from A (indicated by white box). Scale bars are a) 100 μm and 
b) 10 μm. Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
Figure 14: Photoreceptor segment-formation under the EM.  
Electron microscopic sections from a) a RO cultured in the RoC with RPE (RoC w/ RPE), b) a RO cultured in 
the RoC without RPE (RoC w/o RPE), and c) a dish-cultured RO (dish RO). All ROs were 181 days old, 
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cultured for 7 days under the respective condition. Red stars indicate outer segment-like structures that 
were identified by the formation of membrane stacks as shown exemplarily in higher magnification in d). 
The number of outer segments per imagine was counted on different images and the number of segments 
per 100 μm was calculated in e) (RoC w/ RPE n=3; RoC w/o RPE n=4; Dish RO n=3). Statistical analysis was 
performed of RoC w/ RPE vs. RoC w/o RPE as well as of RoC w/ RPE vs. dish RO. Scale bars are a-c) 5 μm, d) 
1 μm. Error bars = S.E.M. *p-value < 0.05 (one-way-ANOVA with Bonferroni post-hoc test). Figure adapted 
from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.4.2. Functional analysis of interaction using phagocytosis assay 
5.4.2.1. Phagocytosis of bovine outer segments out-of-chip 
Another major function of RPE cells in vivo is the phagocytosis and digestion of shed 
photoreceptors outer segment (POS) discs (Sparrow et al., 2010). The first step to verify this 
function was to test whether our hiPSC-derived RPE cells were actually able to phagocytose 
outer segments in culture. Therefore, we performed a preliminary phagocytosis assay with 
hiPSC-derived RPE cells out-of-chip, in standard dish culture with cells seeded on cover slips. 
Cells were incubated for 2 h with bovine photoreceptor outer segments. Then, 
immunohistochemistry was performed using the early endosomal antibody EEA1, to observe 
endosomes and using rhodopsin as marker for rod photoreceptors to monitor phagocytotic 
uptake of photoreceptor segments into the RPE cells. After the 2 h incubation, we found a 
clear increase in EEA1 signal (Figure 15a), indicating an increase in early endosome 
formation. Further, rhodopsin-positive signals could be observed inside the RPE cells (Figure 
15b). We concluded that our hiPSC-derived RPE cells were indeed able to take up bovine 
outer segments.  
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Figure 15: Phagocytosis assay with bovine outer segments on hiPSC- derived RPE cells out-of-chip. 
 hiPSC-derived RPE cells in standard dish culture grown on cover slips were incubated for 2h with bovine 
photoreceptor outer segments and then stained using immunohistochemistry for the early endosome 
marker EEA1 (a, green) or stained for the photoreceptor-marker rhodopsin (b, green) and the cytoskeleton 
marker phalloidin (b, red). Images at the top show untreated RPE cells, images at the bottom show RPE 
cells after the 2h incubation. DAPI (blue) was used to mark the cell nuclei. Scale bar = 40 μm. Figure 
adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.4.2.2. Phagocytosis of shed photoreceptors in the retina-on-a-
chip 
As a next step, co-culture chips were analyzed for signs of phagocytotic activity. For that 
purpose, segments of ROs were again labeled with PNA-lectin before co-culture was 
initiated. If RPE cells were able to phagocytose RO-segments also inside the chip setup, then 
PNA-lectin positive signals should be found inside the RPE cells. Prior to this experiment, RPE 
cells were labeled with an IRBP-GFP construct in green, for identification. Co-culture was 
initiated, and chips were cultivated for 1 day before the setup was analyzed using live-cell 
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imaging and optical sectioning. The x-z-projection as well as a 3D-projection of respective 
localization of POS and RPE in Figure 16a, showed that PNA-lectin positive signals could be 
found inside the green IRBP-GFP labelled RPE cell layer. 
To verify that the positive signals obtained were actually parts of the photoreceptor 
segments, we used whole-mount in situ immunohistochemistry with a rhodopsin antibody 
after fixation of the 1-day-old co-cultures. A co-localization of the green PNA-lectin and the 
red rhodopsin-positive signals could be identified as yellow signals in Figure 16b. 
Further, also in this setup, we aimed to visualize formation of early endosomes as a sign of 
an ongoing early phagocytotic process and as it could be observed with bovine outer 
segments out-of-chip before. Therefore, RPE cells were labeled with an early-endosomes-
GFP construct before cells were used for on-chip-culture and co-culture with ROs was 
initiated for 1 day. The projection of an optical sectioning after immunohistochemistry for 
rhodopsin showed a co-localization of the GFP- and rhodopsin-positive signals inside the 
layer of RPE cells that were marked with a phalloidin-antibody (Figure 16c). Co-localizations 
are indicated with arrows. 
Finally, phagocytosis in the cell will also lead to changes on an ultrastructural level. 
Therefore, we aimed to verify the results using electron microscopy after co-cultivation over 
a period of 7 days. Phagocytotic vesicles containing parts of photoreceptor outer segments, 
that can be identified by dense membrane-disks, were found inside the RPE cells, together 
with vesicles containing electron-dense material as indication of an ongoing digestion of 
lipid-membranes or debris digestion (Figure 16d). 
Taken together, these results indicate that inside the RoC setup the RPE cells indeed have 
the ability of phagocytotic uptake of shed photoreceptor outer segments from the ROs. 
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Figure 16: Functional analysis of the co-culture in the RoC using phagocytosis assay.  
Co-cultures of ROs and RPE in the RoC setup were analyzed for signs of phagocytotic activity of the RPE. a) 
Photoreceptor outer segments (POS) of ROs were labeled with PNA-lectin (red), while RPE cells were 
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labeled with IRBP-GFP (green) before chip cultivation. After 1 day, live-cell imaging was used and both 
tissues are represented as x-z-projection, as well as 3D-projection to discriminated positions of POS vs. RPE 
cells. b) Immunohistochemistry of co-cultures from a), stained with PNA-lectin (green) as a photoreceptor 
segment marker, as well as with rhodopsin-antibody for rod photoreceptors (red). The IRBP-GFP signal of 
the RPE cells is depicted in white. c) Whole mount staining of day 1 co-cultures with RPE marked with 
early-endosomes constructs (green) before chip culture was initiated and subsequent 
immunohistochemistry was performed for rhodopsin (red, rods) and phalloidin (magenta, cytoskeleton of 
RPE cells). d) After co-cultivation of ROs in the RoC for 7 days, electron microscopy of RPE cells was 
performed. Signs of phagocytotic vesicles containing membrane stacks are marked with red arrows. Signs 
of phagocytotic vesicles containing electron-dense material as indication of an ongoing digestion of lipid-
membranes or debris digestion are marked with blue arrow. Scale bars are a) 10 μm, c) 50 μm, d) 1 μm. 
Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.5. Proof-of-principle study: the retina-on-a-chip as drug-
testing device 
5.5.1. Chloroquine 
As a proof-of-concept study to test whether the RoC can be used as a drug testing device, we 
chose 2 chemicals with known retinopathic side effects.  
Chloroquine is an anti-malaria drug that is known to lead to retinopathy if patients are 
treated long-term (Elman et al., 2009). The retinopathic effect was shown in literature to be 
at least partially associated with lysosomal dilation, leading to lysosomal dysfunction (Chen 
et al., 2011; Mahon et al., 2004; Rosenthal et al., 1978). 
As a preliminary experiment to assess the necessary concentrations, we analyzed the effect 
of increasing concentrations (0, 20, 40, 80 μg/ml) of chloroquine on hiPS-RPE out-of-chip in 
standard dish-cultures (grown on coated coverslips) (Figure 17). These concentrations were 
known from literature for the treatment of ARPE-19 cells (Chen et al., 2011). After 24 h of 
treatment, we found clear signs of vacuolization to be observed under the phase-contrast 
microscope in a dose-dependent fashion (Figure 17a). 
Cells on coverslips were then stained using immunohistochemistry against cleaved caspase 3 
(CASP3) to assess a potential apoptotic effect and stained against the lysosomal membrane 
protein lysosome-associated marker protein 2 (LAMP2) to assess the impact on lysosomes in 
the cells (Figure 17b). Already the lowest concentration tested (20 μg/ml) led to a clear 
increase in LAMP2 signal (Figure 17b) indicating an increase in lysosome size that also 
corresponds to previous phase contrast images (Figure 17a). At higher concentrations, the 
effect increased gradually. Only at the highest concentration (80 μg/ml) however, an 
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elevated CASP3 signal could be detected, indicating apoptosis of the respective cells (Figure 
17b). Consequently, we chose the lowest (20 μg/ml) and highest (80 μg/ml) concentration to 
be then tested in the RoC setup. 
- 79 - 
 
 
Figure 17: Effect of increasing concentrations of chloroquine on RPE cultured in the dish. 
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a) hiPS-derived RPE that had been cultured on coverslips in 24-well plates was treated over 24 h with CQ at 
20, 40 or 80 μg/ml and compared to untreated wells in the same plate (CTRL). a) Phase-contrast images of 
treated cells. b) Cells were fixed and stained using immunohistochemistry against the markers cleaved 
caspase 3 (CASP3, red) and against the lysosomal-membrane protein LAMP2 (green). Nuclei were marked 
with DAPI in blue. Scale bars: 40 μm. Figure adapted from Achberger, Probst and Haderspeck et al., 2019 
(CC BY 4.0). 
 
Co-culture chips that had been cultured for 3 days were treated with chloroquine at 20 
μg/ml and 80 μg/ml over a period of additional 3 days. Already under light-microscopic 
observation, morphological changes in the organoid could be monitored, since the shape 
became less round, the borders less sharp and the outer layer increasingly blurry (Figure 
18a). To verify this observation, the drug-induced retinopathy was analyzed using propidium 
iodide (PI) staining since CASP3 staining did not seem sensitive enough in previous 
experiments (Figure 17b). PI is a dye marking dead or dying cells since their plasma 
membrane becomes leaky, allowing the dye to enter the cell (Crowley et al., 2016). The PI-
signal intensity was quantified and compared to a non-treated control cultured over the 
same period of time. Whereas for the low concentration (20 μg/ml) of chloroquine, no 
obvious increase in PI signal could be observed, there was a significant increase after 
treatment with the high concentration (80 μg/ml) of chloroquine (Figure 18b). Moreover, 
the PI signal intensity from the area only covered by RPE was analyzed. Also in this case, a 
significant increase in signal intensity compared to the RPE-only area in control chips could 
be observed. 
The treated co-culture chips where then stained using immunohistochemistry against the 
marker LAMP2. Whereas for the low chloroquine concentration, only a minor increase in 
LAMP2 signal could be monitored, the high concentration led to a strong lysosomal 
dilatation, since the LAMP2-marked vesicles became greater in size and a strong signal was 
visible (Figure 18c). The positive LAMP2 signal was visible in the RPE as well as in the RO.  
Consequently, the retinopathic, as well as the lysosomotropic effect of the drug can be 
recapitulated in vitro in the RoC setup. 
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Figure 18: Effect of chloroquine treatment on the retina-on-a-chip.  
Retinal organoids (d243-260) and RPE were cultured in the RoC and treated over a period of 3 days with 
chloroquine (CQ) at 20 or 80 μg/ml. An untreated control (CTRL) was used as reference. a) On day 3, chips 
were stained with propidium iodide (PI, red, cell death) and live-cell fluorescence imaging of different 
treatment conditions was performed. Bright-field images and fluorescence-images were taken at different 
focus-levels: first, focusing on the RPE level (left) and second, focusing on the organoid level (right). Nuclei 
were stained with HOECHST (blue). b) Quantification of the PI signal intensity in the control (CTRL), the 20 
μg/ml, and 80 μg/ml condition, as calculated relative to the control and shown for the combined RPE-
organoid signal, and for the RPE-only signal (n=6-11 chip chambers per condition, 3 independent 
experiments). Statistically testing was performed of treated vs. control-intensities. c) Chloroquine-treated 
RoC were fixed and stained against the lysosomal marker LAMP2 (green) using immunohistochemistry. 
Nuclei were stained with HOECHST (blue). Error bars: S.E.M. ***p-value<0.001 (one-way-ANOVA with 
Dunnet post-hoc test). Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
 
5.5.2. Gentamicin 
Gentamicin is an antibiotic drug used for example for the treatment of endophthalmitis 
(Hancock et al., 2005). We used this drug as another proof-of-concept to replicate known 
pharmacologic side-effects. Again, the effect of the drug treatment was analyzed using PI 
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staining to visualize drug-induced retinopathy with live-cell imaging (Figure 19a). Two 
different concentrations (0.5 mg/ml and 2.5 mg/ml) of gentamicin that had been previously 
verified, were used to treat RPE with ROs in the co-culture chip over a period of 6 days. The 
treated conditions were compared to non-treated controls in medium with diluent solution. 
Further, also ROs cultured in the RoC without RPE and treated with the same concentrations 
of gentamicin were compared to non-treated controls. The intensity of the PI signal was 
measured and is shown relative to the control-chip intensity in Figure 19b. 
The low concentration (0.5 mg/ml) of gentamicin led to no obvious changes in PI signal 
intensity in the co-culture condition (RO + RPE), whereas in the RO-only condition, a minor 
increase in cell death could be observed. The high concentration (2.5 mg/ml) of gentamicin 
however, had a significant effect on cell viability in the co-culture RoC (RO + RPE), as well as 
in the RO-only setup, confirming a retinopathic effect of the drug in vitro.  
However, the measured intensities always reflect the combined signals from RO plus RPE in 
the co-culture condition. To be able to compare the effect that the presence of RPE cells has 
on treated ROs, the intensities of RPE were subtracted from the combined signals. This 
revealed that for the 0.5 mg/ml treatment, no obvious effect can be observed if RPE is 
present as opposed to an increase in cell death if RPE is missing, indicating a protective 
effect of RPE presence for low concentrations of gentamicin.  
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Figure 19: Effect of gentamicin treatment on the retina-on-a-chip. 
ROs (d243-260) and RPE were cultured in the RoC and treated over a period of 6 days with gentamicin 
(GM) at 0.5 mg/ml and 2.5 mg/ml. A diluent-treated control (CTRL) was used as reference. a) Live-cell 
imaging of different treatment conditions of RoC stained with PI. On the left, the co-culture RoC is shown, 
including ROs and RPE. On the right, the RoC only contains ROs. Bright-field and fluorescence images are 
shown. The PI signal (red) was measured for every condition. b) Quantification of the PI signal intensity in 
the control (CTRL), the 0.5 mg/ml, and 2.5 mg/ml condition, as calculated relative to the control and 
shown for the combined RO + RPE signal, and for the RO-only signal (n=6-11 chip chambers per condition, 
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3 independent experiments). A direct comparison of the signal intensity between the RoC with and without 
RPE for the low concentration (0.5mg/ml) GM is also provided. Error bars: S.E.M. *p-value<0.05, ***p-
value<0.001 (b) one-way-ANOVA with Dunnet post-hoc test c) two-way-ANOVA with Bonferroni post-hoc 
test). Figure adapted from Achberger, Probst and Haderspeck et al., 2019 (CC BY 4.0). 
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6. Discussion 
6.1. Individual culture chips 
We started the chip design for individual RPE or RO-cultures to make sure that a) individual 
tissues are cultured in the chip under optimal conditions and b) to establish ideal processes 
for loading, medium supply and analysis with suitable read-out methods. 
As a first step, we verified that RPE cells as well as ROs can survive in the chip-culture and do 
not change characteristic marker expression as well as morphological characteristics.  
After 3 days in the chip system, ROs did neither change morphology and microscopic 
structures, nor did they change marker expression of different retinal cell types. 
Even fine microscopic structures of photoreceptors and their outer segments can still be 
found after chip-culture which shows that this method of cultivation is suitable to preserve 
such delicate structures. These results provide a first indication that culture of ROs in the 
chip system is not inferior to standard dish culture. Nevertheless, the segments initially 
observed inside the chip can still not clearly be referred to as mature “outer segments” since 
they are far from the length a photoreceptor outer segment would possess in vivo.  
For RPE cells, the appearance was more difficult to judge since the confluent cell layer 
cannot simply be transferred to the chip but has to be dissociated instead. This is necessary 
to generate a cell monolayer adherent to the membrane integrated inside the chip. 
However, dissociation of the cells by enzymatic passaging can lead to a change of 
metabolism which becomes obvious by the fact that RPE cells can lose their pigmentation if 
passaged at low density (Shang et al., 2018) or if dissociated from a sphere, like in our case. 
It is known that especially the loss of cell contacts and polarity in this context can lead to loss 
of pigmentation in these cells (Shang et al., 2018). We have observed that after 1-3 months 
of culture under serum-free conditions, pigmentation can be restored as it was shown 
before for ARPE-19 cells (Ahmado et al., 2011; Luo et al., 2006). Of course, this long period of 
culture is not feasible when transferring the cells into the chip setup. Nevertheless, the 
initial step of cell dissociation cannot be avoided in this protocol. Therefore, it is essential to 
culture the cells for several months with addition of the appropriate growth factors 
(Ohlemacher et al., 2015) prior to chip-culture. When transferring the RPE cells into the chip, 
they then have to be passaged at high cell density to avoid loss of pigmentation and loss of 
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hexagonal shape (Shang et al., 2018). Using this method however, it is possible to generate 
RPE monolayers inside the chip that have both, the typical hexagonal shape and 
pigmentation (see Figure 3e and Figure 4c). 
On mRNA level, all analyzed markers of ROs and RPE were expressed in the chip at least to a 
similar level compared to standard dish-culture. One marker to highlight here was ZO1, that 
was significantly higher expressed in chip conditions for the RPE and well as for the RO-chips. 
This molecule is part of tight-junctions at cell-to-cell borders, responsible for forming a tight 
barrier in epithelial cell types (Campbell et al., 2017). Further, it is part of the outer limiting 
membrane (OLM) of the neuroretina (Omri et al., 2010). It is possible that under the setting 
of the chip, especially the cell-to-cell-border formation is improved. This might be due to 
reduced movement of liquids and reduced shear forces (due to missing pipetting) that 
otherwise could cause weak junctions to break again. 
These results provide indications that inside the chip system, the OLM of ROs is improved 
and the RPE can form a dense epithelial layer and hence, enabling a more physiological 
culture. 
The goal of these initial experiments was to show that the chip-culture itself is not inferior to 
standard culture, therefore only short cultivation periods were chosen. If choosing longer 
periods for future experiments, it is possible that the increased expression of several other 
markers can be observed, as it was already the case for ZO1. 
Taken together, these results indicate that cultivation of RPE cells and ROs inside a defined 
chip-setup is not inferior, possibly even superior to cultivation in standard dish culture. 
These findings allowed us to introduce both tissues into a combined chip setting, the retina-
on-a-chip. 
 
6.1.1. Immunohistochemistry of RPE cells inside individual culture 
chips 
When analyzing the expression of typical RPE markers on protein level, we found already 
after 7 days of culture the marker ZO1 as well as MITF to be expressed in the chip-culture. 
This is in line with previous observations on mRNA level after 7 days of culture. 
However, we observed that after 7 days, the marker ZO1 is not as regularly spaced 
compared to 14 days in culture. This might indicate that RPE cells need this time to regain 
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their regular quasi-hexagonal shape. As mentioned earlier, RPE cells require a certain time in 
the chip before they should be used for experiments. 
The melanosomal marker Melanoma GP100 was found to be positive in vesicles filling the 
cell bodies (Figure 4c right). This might be an indication that, even if pigmentation is not 
clearly visible under the bright-field microscope at that time point, pigmentation markers 
are still expressed. This observation also verified the results from mRNA expression levels. 
Consequently, RPE cells show signs of maturity after 14 days in chip-culture. 
 
6.1.2. Polarization of RPE cells inside individual culture chips 
Since a functional RPE is of key importance for maintaining the function of the neuroretina 
(Kay et al., 2013) and therefore, also for a working physiological model system of the retina, 
we analyzed this tissue in greater detail. One aspect to judge the degree of physiology is a 
morphological and functional polarization of the RPE cell layer (Kay et al., 2013) which is 
essential for example for the selective transport of molecules and for the maintenance of 
different subretinal spaces with specialized chemical compositions (Cao et al., 2018; Kay et 
al., 2013; Sonoda et al., 2009). 
One morphological sign of RPE polarization is the formation of microvilli processes on the 
apical side, which highly increases the surface and therefore the contact area between RPE 
and photoreceptor segment tips  (Kiser et al., 2014). We analyzed microvilli formation using 
immunohistochemistry by staining for the marker ezrin, which is a membrane-organizing 
phosphoprotein and can be used as marker of polarization (Kivelä et al., 2000). Clearly, the 
ezrin-positive signals could only be found at the apical surface of the RPE cells. This was 
additionally verified using electron microscopy of the RPE layer which also showed long 
microvilli processes at the apical side, while at the basal side a dense layer was found that 
morphologically appeared similar to the basal lamina that would form the RPE’s part of the 
Bruch’s membrane in vivo (Aisenbrey et al., 2006). 
A second indication for polarization of RPE cells is the polarized and directed secretion of 
certain growth or trophic factors (Kay et al., 2013). We analyzed the secretion of VEGF-A as 
an angiogenic growth factor secreted predominantly to the basal side of RPE cells since this 
is the side facing the choriocapillaries (Kay et al., 2013; Witmer et al., 2003). While in 
transwell cultures of RPE cells, the VEGF-A secretion was significantly higher towards the 
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basal side, we found a strong tendency but no significant results in the chip environment. 
This can be due to several factors. It is possible that VEGF-A secretion per se is not as 
polarized because cells are not as mature and polarized like in the transwell setting. 
However, it needs to be taken into consideration that measured volumes in the chip setup 
are much lower than in the transwell setup. Moreover, it was challenging to generate an 
exact equal volume output from apical and basal channels, since even small resistances in 
the channels can lead to distortions. While we accounted for volume differences between 
apically and basally collected volumes by respective calculations, it cannot be excluded that 
the measurement was not as precise as necessary. 
However, if we combine results from ezrin staining, electron microscopy and growth factor 
secretion, we can conclude that the RPE inside the chip setup is indeed strongly polarized.  
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6.2. The retina-on-a-chip as a co-culture device for integration 
of RPE and retinal organoids  
Since different methods of loading and cultivation were tested already in individual culture 
chips, we were able to integrate both tissues into a combined chip, by first loading RPE and - 
following its attachment to the membrane - loading ROs on the next day. 
Our goal was then to analyze if the co-culture RoC actually leads to improved cultivation and 
more physiological conditions. Therefore, we looked at different aspects of the interaction 
and interplay of both tissues. Those aspects analyzed were the distance and physiological 
setup between RPE and ROs as well as an improved photoreceptor segment formation and 
phagocytosis by the RPE. 
6.2.1. Analysis of distance 
One aspect to judge a physiological setup inside the RoC is the distance between the RPE 
and the RO. We used live-cell imaging of labeled ROs and labeled RPE cells within the co-
culture RoC setup to analyze the distance between both tissues directly after setup. The 
mean distance found via this method was 5 μm. It is possible that this method of distance 
measurement is not precise enough to make a statement on the absolute distance, since it 
depends largely on the number of optical stacks used and imaging from the side was not 
possible. However, since 12 different chip compartments were used, we can still conclude 
that one can find a consistency over different experiments regarding the distance. 
In vivo, one would expect to find zero distance between both tissues, since the RPE cell 
would normally engulf the photoreceptor segments tips with their microvilli processes 
(Kevany and Palczewski, 2010). Only such a close apposition allows the phagocytotic uptake 
of cell debris and shed segments, while at the same time supplying the photoreceptor cell 
with nutrition and keeping up the visual cycle (Kevany and Palczewski, 2010; Sparrow et al., 
2010). However, in our RoC setup, we assume that the photoreceptor outer segments from 
the ROs are not fully mature yet and therefore, do not have the same length as they would 
have in vivo. Consequently, zero distance between ROs and RPE would not allow the 
segments to grow longer. Indeed, we found that after 7 days of co-culture, the distance 
between segment tips and RPE seems to be reduced. It needs to be noticed that whole-
mount staining was used at this time-point and therefore, a different method of cell labeling, 
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since labeling with PNA-lectin will not be visible for longer than 3 days. Moreover, rhodopsin 
signals at this time-point were also found within the layer of RPE cells (as a possible 
indication of disk shedding), making it difficult to point out segments that are still part of the 
RO. Therefore, we can conclude that ROs and RPE within the RoC are in very close apposition 
and that this positioning can be replicated. 
6.2.2. Analysis of segment formation  
The second aspect to judge a physiological interaction was whether the presence of RPE in 
the chip and the setup inside the RoC can lead to improved photoreceptor segment 
formation. 
Even though recent publications were able to show that outer segment formation can be 
achieved in photoreceptors of ROs, these outer segments are still described as rudimentary 
and developing (Li et al., 2018; Mellough et al., 2019). It is known that the close contact 
between RPE and photoreceptors can influence the spatial organization of the retina with 
regard to photoreceptor outer segment differentiation and orientation (German et al., 
2008). Therefore, it is possible that bringing both tissues into the required close contact, an 
improvement of photoreceptor segment maturation can be achieved. 
Here, segment formation of the photoreceptors of ROs in the RoC setup was analyzed using 
immunohistochemistry and electron microscopy. We found indications that not only new 
segments are formed within the RoC within only 7 days, but moreover the RoC even seems 
to improve this process compared to standard dish-cultured ROs. This can be due to several 
factors: First, it can be due to the absence of shear forces in the area around the ROs, while 
in standard dish-culture, the process of medium change or maybe even movement of the 
plate itself, might destroy some of the developing segment-structures. Second, the presence 
of RPE in a physiological setup might help to improve segment formation, since RPE cells 
produce trophic factors for the photoreceptors and also have the ability to phagocytose 
shed outer segments as well as debris (Molday and Moritz, 2015; Steinberg, 1985; Strauss, 
1995). A combination of these factors could help to provide a physiological environment that 
allows segments to grow and keep photoreceptors in a close-to-physiological state.  
Nevertheless, one needs to take into account that segment formation was not monitored 
with live-cell imaging here and that preparation of the tissue as microscopic slides (either for 
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IHC or EM) was necessary. This process can always result in tissue destruction and the actual 
number of segments in each condition might vary depending on the methods used.  
For future experiments, live cell monitoring of segment formation and longer cultivation 
periods might reveal the full impact that this RoC setup has on outer segment formation. 
6.2.3. Analysis of phagocytosis 
The third aspect regarding functional interaction between both tissues in the RoC was the 
analysis of the RPE’s ability for phagocytosis of photoreceptor segments. Ingestion and 
phagocytosis of membranes stacks of the photoreceptor outer segments that continuously 
shed these structures, is an important function of the RPE during the visual cycle as well as 
for the renewal of segment structures (Kevany and Palczewski, 2010; Sparrow et al., 2010). 
To answer whether this functional ingestion can actually be observed in the RoC, we have 
shown with live-cell imaging and immunohistochemistry that different markers for 
photoreceptor segments can be found inside the RPE cells after co-cultivation with ROs 
inside the chip. Even though it provides the strong impression, these results cannot exclude 
that the identified parts of photoreceptors are only within in the layer of RPE cells but not 
actually taken up inside a cell. Therefore, in addition, signs of early endosome formation 
were analyzed, indicating a phagocytotic process which involves fusion of these early 
endosomes with phagosomes and formation of phagolysosomes during the digestion of 
particles (Kevany and Palczewski, 2010). The co-localization of early endosomal-bodies with 
rhodopsin provides an indication that the segment structures have actually been ingested by 
the cell and have initiated a phagocytotic process. Further, also on an ultrastructural level, 
morphological signs of phagocytotic bodies could be overserved. 
Altogether, these results indicate that a physiological setup and interaction between the ROs 
and RPE inside the RoC can be achieved and that the RPE generated from hiPSC is capable of 
a functional digestion. Nevertheless, the rate of phagocytosis vs. disk renewal cannot be 
observed in this setup to state whether the degree of phagocytotic uptake is close to the 
physiological setting. 
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6.3. Proof-of-principle study: the retina-on-a-chip as drug-
testing device 
One of the goals for developing a retina-on-a-chip system was the possibility to use it as a 
drug-testing device for the discovery of new drugs as well as for toxicology assessment of 
existing substances. We analyzed two substances with known retinopathic side-effects 
suitable for a proof-of-principle study in the RoC: chloroquine and gentamicin.  
6.3.1. Chloroquine 
Chloroquine as well as its metabolite hydroxychloroquine are well known drugs that are 
used for the treatment of malaria and rheumatic diseases like rheumatoid arthritis (Ding et 
al., 2016; Stokkermans and Trichonas, 2019). Both substances can severely affect the retina, 
by binding to melanin in RPE cells and also by affecting the lysosomal activity in those cells, 
leading to reduced phagocytosis which can then also affect photoreceptors of the retina 
(Stokkermans and Trichonas, 2019). The effects include lysosome enlargement due to an 
accumulation of the drug where it also leads to a change in pH and consequently, to 
lysosomal dysfunction (Chen et al., 2011).  
In the RoC system, we aimed to recapitulate this lysosomotropic effect by visualizing 
lysosomes after treatment with chloroquine. While treatment of RPE with chloroquine in 
standard dish culture had a strong effect at already 20 μg/ml, the lysosomal dilation and cell 
death in the RoC only becomes visible at higher concentrations. This might be due to several 
reasons.  
One technical factor might be the differences in the optical properties of the microscopic 
setup between chip setup and standard dish culture, including different refraction of light of 
PDMS as fabrication material, as well as different background fluorescence that makes it 
difficult to compare between both setups. Further, it is known that PDMS which the chip is 
primarily made of, is able to absorb substances, depending largely on their chemical 
properties.  
Even though the mentioned reasons might have influence on the necessary drug 
concentration, is was still possible to replicate the drug’s effect on cell viability and 
lysosomal enlargement in the chip setup. Chloroquine as a drug is used over long periods for 
the treatment in patients with malaria (Ding et al., 2016). As seen in our RoC, this treatment 
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can have consequences for the sight of the patient. The usage of the RoC as a drug testing 
device could be verified by these proof-of-principle experiments. 
6.3.2. Gentamicin 
The antibiotic drug gentamicin was another candidate to be tested in the RoC system. This 
aminoglycoside is used for example for treatment of endophthalmitis and anterior segment 
infections (Hancock et al., 2005). Besides other side effects, local administration can also 
lead to ocular toxicity, including retinal damage (Hancock et al., 2005; McDonald et al., 1986; 
Zemel et al., 1995). 
We treated the RoC system with the drug over several days and monitored effects by 
measurement of PI signal intensities. The setup that was necessary for microscopic 
observation of fluorescence intensities only allowed us to detect combined signals from 
both, RO and RPE. PI as marker for cell death, also does not allow to distinguish both cell 
types. Consequently, we had difficulties to state which cell type is primarily affected and also 
whether the co-culture of both tissues has any effect on cell survival after drug treatment. 
To account for differences in PI signal between both tissues, we subtracted the observed 
intensities of the RPE signal in the surrounding area from the co-signal directly underneath 
the RPE. This could then be compared to an RPE-free condition and gave us a hint, that there 
might be indeed an influencing effect of the RPE, leading to less cell death in the co-culture 
condition, although this effect was not significant. A protective effect might either be due to 
the barrier function of the RPE or to characteristics of the cells themselves. Indeed, it is 
known from in vivo experiments that ocular pigmentation in rabbits can protect them from 
gentamicin-induced retinal toxicity (Zemel et al., 1995). Responsible for this effect seems to 
be the binding of gentamicin by melanin (Zemel et al., 1995). 
However, this way of quantifying cell death is only indirectly measuring fluorescence 
intensities from the ROs. To make definitive statements, other ways of cell viability 
measurement would be necessary, for example live cell microscopy from the side of the 
chip. Nevertheless, it gives us a hint that also the influence of the RPE-presence can be 
monitored in our RoC setup which might be of great benefit when monitoring disorders 
involving primary RPE cell death. Further, known retinopathic effects of the antibiotic 
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gentamicin known from literature could be replicated, showing again the suitability of the 
RoC as a drug-testing device.  
7. Further development and outlook 
Although there have been other publications aiming to introduce single retinal cells (Mishra 
et al., 2015; Su et al., 2015) or retinal tissue from mice (Dodson et al., 2015b) into a microfluidic 
device, this is the very first chip system merging organ-on-a-chip technology with retinal 
organoids derived from human induced pluripotent stem cells. 
The microfluidic channels integrated in the chip system enable vasculature-like perfusion. 
However, the current retina-on-a-chip setup does not include any other cell types (like 
immune or endothelial cells) that do not originate from retinal progenitors. If endothelial cells 
would be integrated into a future version of the chip, this might not only help to improve 
supply with nutrients and oxygen even further, but it can also help to build a full blood-retinal 
barrier, which requires endothelial parts. The blood-retinal barrier is important to control 
transport of different substances to and from the retina and therefore homeostasis of the 
retinal microenvironment (Cunha-Vaz, 1998; Steinberg, 1985). 
Several publications reported different attempts to develop a blood-retinal barrier (Chen et 
al., 2017; Yeste et al., 2018). However, so far none of these have combined their system with 
a neural retina with all different layer but have been restricted to endothelial and RPE cells. 
The integration of the blood-retinal barrier into our system would hold great potential for the 
investigation of the pathomechanisms of several disorders involving a disruption of retinal 
barrier functions such as diabetic retinopathy. Further, the emulation of a barrier is also 
essential when analyzing how drugs impact the retina when applied systemically. 
 
Another option for further development can concern the chip fabrication material used. PDMS 
has some clear advantages that make it a suitable material for chip production especially when 
several rapid adaptations in prototypes are required. These advantages include 
biocompatibility, optical clarity, gas permeability, inexpensiveness and ease of handling (Huh 
et al., 2011). Besides these desirable properties, PDMS also has certain characteristics that can 
lead to limitations in chip use: It absorbs small hydrophobic molecules and is therefore not 
suitable for specific experiments with certain drugs or fluorescent dyes (Huh et al., 2011). For 
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a next generation of chip, the utilization of a different kind of plastic would seem reasonable, 
such as PMMA for instance, which is also inexpensive and features good mechanical/chemical 
properties (Liga et al., 2016; Zhang et al., 2009). 
 
The chip as model system for the human retina can bring important insights and is a suitable 
tool for in vitro experiments, despite the aforementioned options for improvement. 
In this study, we only used drugs with already known side effects on the retina. However, in 
future studies, newly developed pharmaceuticals could be tested for retinal effects in such a 
setup. Those studies would normally require extensive testing in animals, such as mice or 
rabbits. As described before, the ethical as well as the financial aspects of testing huge 
numbers of animals for every potential drug, ask for suitable alternatives. In certain aspects 
the retina-on-a-chip shows some advantages over testing of animals since these species have 
eyes and retinae with different morphological and physiological characteristics. The testing of 
human cells and tissues can therefore bring along important insights that could not be gained 
from other species with different properties. 
Further, for many retinal disorders there are still no suitable drugs known to ameliorate the 
symptoms or cure the disease. Large-scale testing of candidate drugs in a close-as-possible-
physiological setup will be necessary to find such urgently needed treatments. This requires 
disease models that are able to accurately represent the condition in a patient’s eye. The 
retina-on-a-chip is the first step towards solving this problem since it allows to integrate 
human retinal cells from any background. In this way, either stem cells that originate from 
patients can be used for differentiation of retinal cells, or the disease can be introduced by 
genetically engineering the respective stem cells or retinal cells. Even drug-induced disorders 
can be used as model to help find protective agents. 
Lastly, the retina-on-a-chip can help to generate important insights on retinal development 
itself, as well as on the important interplay of different tissues of the eye, such as the neural 
retina and the pigmented epithelium of the retina. 
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